# EDGAR Filing Document

**Accession Number:** 0001024305
**File Stem:** 0001024305-23-000012
**Filing Date:** 2023-2
**Character Count:** 277042
**Document Hash:** e4623365187bc5a0363ad5acb9fb343f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001024305-23-000012.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0001024305-23-000012

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 106

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230208

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** COTY INC.
- **CENTRAL INDEX KEY:** 0001024305
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **IRS NUMBER:** 133823358
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35964
- **FILM NUMBER:** 23599019

**BUSINESS ADDRESS:**
- **STREET 1:** 350 FIFTH AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10118
- **BUSINESS PHONE:** 212-389-7300

**MAIL ADDRESS:**
- **STREET 1:** 350 FIFTH AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10118

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** COTY INC /
- **DATE OF NAME CHANGE:** 19961004

?xml version="1.0" ? coty-20221231

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**Form 10-Q** 

**(Mark One)**

---

| | | |
|:---|:---|:---|
| ☒ | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| **FOR THE QUARTERLY PERIOD ENDED** | **FOR THE QUARTERLY PERIOD ENDED** | **DECEMBER 31, 2022** |
| **OR** | **OR** | **OR** |
| ☐ | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| **FOR THE TRANSITION PERIOD FROM&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** | **FOR THE TRANSITION PERIOD FROM&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** | **FOR THE TRANSITION PERIOD FROM&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** |
| **COMMISSION FILE NUMBER** | **COMMISSION FILE NUMBER** | **001-35964** |

---

**COTY INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **Delaware** | **13-3823358** |
| **(State or other jurisdiction of incorporation or organization)** | **(State or other jurisdiction of incorporation or organization)** | **(I.R.S. Employer Identification No.)** |
| **350 Fifth Avenue,** | **350 Fifth Avenue,** | |
| **New York,** | **NY** | **10118** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**(212) 389-7300** 

**Registrant's telephone number, including area code**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &nbsp;&nbsp;&nbsp;&nbsp;Yes 🗷&nbsp;&nbsp;&nbsp;&nbsp; No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &nbsp;&nbsp;&nbsp;&nbsp;Yes 🗷&nbsp;&nbsp;&nbsp;&nbsp; No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smaller reporting company | ☐ |
| | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ |

---

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp; No 🗷

**Securities Registered Pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Class A Common Stock, $0.01 par value | COTY | New York Stock Exchange |

---

At January 31, 2023, 852,595,821 shares of the registrant's Class A Common Stock, $0.01 par value, were outstanding.

------

**COTY INC.**

**INDEX TO FORM 10-Q**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| **<u>[Part I:](#i6b5bcc02c0914a879b0955841c7adee6_10)</u>** | **<u>[FINANCIAL INFORMATION](#i6b5bcc02c0914a879b0955841c7adee6_10)</u>** | |
| <u>[Item 1.](#i6b5bcc02c0914a879b0955841c7adee6_13)</u> | <u>[Condensed Consolidated Financial Statements (Unaudited)](#i6b5bcc02c0914a879b0955841c7adee6_13)</u> | <u>[1](#i6b5bcc02c0914a879b0955841c7adee6_13)</u> |
| | <u>[Condensed Consolidated Statements of Operations for the three](#i6b5bcc02c0914a879b0955841c7adee6_16)[and six](#i6b5bcc02c0914a879b0955841c7adee6_16)[months ended](#i6b5bcc02c0914a879b0955841c7adee6_16)[Dec](#i6b5bcc02c0914a879b0955841c7adee6_16)[ember 3](#i6b5bcc02c0914a879b0955841c7adee6_16)[1](#i6b5bcc02c0914a879b0955841c7adee6_16)[, 2022 and 2021](#i6b5bcc02c0914a879b0955841c7adee6_16)</u> | <u>[1](#i6b5bcc02c0914a879b0955841c7adee6_16)</u> |
| | <u>[Condensed Consolidated Statements of Comprehensive Income (Loss) for the three](#i6b5bcc02c0914a879b0955841c7adee6_19)[and six](#i6b5bcc02c0914a879b0955841c7adee6_19)[months ended](#i6b5bcc02c0914a879b0955841c7adee6_19)[Dec](#i6b5bcc02c0914a879b0955841c7adee6_19)[ember 3](#i6b5bcc02c0914a879b0955841c7adee6_19)[1](#i6b5bcc02c0914a879b0955841c7adee6_19)[, 2022 and 2021](#i6b5bcc02c0914a879b0955841c7adee6_19)</u> | <u>[2](#i6b5bcc02c0914a879b0955841c7adee6_19)</u> |
| | <u>[Condensed Consolidated Balance Sheets as of](#i6b5bcc02c0914a879b0955841c7adee6_22)[Dec](#i6b5bcc02c0914a879b0955841c7adee6_22)[ember 3](#i6b5bcc02c0914a879b0955841c7adee6_22)[1](#i6b5bcc02c0914a879b0955841c7adee6_22)[, 2022 and June 30, 2022](#i6b5bcc02c0914a879b0955841c7adee6_22)</u> | <u>[3](#i6b5bcc02c0914a879b0955841c7adee6_22)</u> |
| | <u>[Condensed Consolidated Statements of Equity for the](#i6b5bcc02c0914a879b0955841c7adee6_25)[t](#i6b5bcc02c0914a879b0955841c7adee6_25)[hree and](#i6b5bcc02c0914a879b0955841c7adee6_25)[six](#i6b5bcc02c0914a879b0955841c7adee6_25)[months ended](#i6b5bcc02c0914a879b0955841c7adee6_25)[Dec](#i6b5bcc02c0914a879b0955841c7adee6_25)[ember 3](#i6b5bcc02c0914a879b0955841c7adee6_25)[1](#i6b5bcc02c0914a879b0955841c7adee6_25)[, 2022 and 2021](#i6b5bcc02c0914a879b0955841c7adee6_25)</u> | <u>[4](#i6b5bcc02c0914a879b0955841c7adee6_25)</u> |
| | <u>[Condensed Consolidated Statements of Cash Flows for the](#i6b5bcc02c0914a879b0955841c7adee6_31)[six](#i6b5bcc02c0914a879b0955841c7adee6_31)[months ended](#i6b5bcc02c0914a879b0955841c7adee6_31)[Dec](#i6b5bcc02c0914a879b0955841c7adee6_31)[ember 3](#i6b5bcc02c0914a879b0955841c7adee6_31)[1](#i6b5bcc02c0914a879b0955841c7adee6_31)[, 2022 and 2021](#i6b5bcc02c0914a879b0955841c7adee6_31)</u> | <u>[7](#i6b5bcc02c0914a879b0955841c7adee6_31)</u> |
| | <u>[Notes to Condensed Consolidated Financial Statements](#i6b5bcc02c0914a879b0955841c7adee6_34)</u> | <u>[9](#i6b5bcc02c0914a879b0955841c7adee6_34)</u> |
| <u>[Item 2.](#i6b5bcc02c0914a879b0955841c7adee6_109)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i6b5bcc02c0914a879b0955841c7adee6_109)</u> | <u>[34](#i6b5bcc02c0914a879b0955841c7adee6_109)</u> |
| <u>[Item 3.](#i6b5bcc02c0914a879b0955841c7adee6_169)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i6b5bcc02c0914a879b0955841c7adee6_169)</u> | <u>[58](#i6b5bcc02c0914a879b0955841c7adee6_169)</u> |
| <u>[Item 4.](#i6b5bcc02c0914a879b0955841c7adee6_172)</u> | <u>[Controls and Procedures](#i6b5bcc02c0914a879b0955841c7adee6_172)</u> | <u>[59](#i6b5bcc02c0914a879b0955841c7adee6_172)</u> |
| **<u>[Part II:](#i6b5bcc02c0914a879b0955841c7adee6_175)</u>** | **<u>[OTHER INFORMATION](#i6b5bcc02c0914a879b0955841c7adee6_175)</u>** | |
| <u>[Item 1.](#i6b5bcc02c0914a879b0955841c7adee6_178)</u> | <u>[Legal Proceedings](#i6b5bcc02c0914a879b0955841c7adee6_178)</u> | <u>[59](#i6b5bcc02c0914a879b0955841c7adee6_178)</u> |
| <u>[Item 1A.](#i6b5bcc02c0914a879b0955841c7adee6_181)</u> | <u>[Risk Factors](#i6b5bcc02c0914a879b0955841c7adee6_181)</u> | <u>[59](#i6b5bcc02c0914a879b0955841c7adee6_181)</u> |
| <u>[Item 2.](#i6b5bcc02c0914a879b0955841c7adee6_184)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i6b5bcc02c0914a879b0955841c7adee6_184)</u> | <u>[59](#i6b5bcc02c0914a879b0955841c7adee6_184)</u> |
| <u>[Item 6.](#i6b5bcc02c0914a879b0955841c7adee6_187)</u> | <u>[Exhibits](#i6b5bcc02c0914a879b0955841c7adee6_187)</u> | <u>[60](#i6b5bcc02c0914a879b0955841c7adee6_187)</u> |
| <u>[Signatures](#i6b5bcc02c0914a879b0955841c7adee6_190)</u> | <u>[Signatures](#i6b5bcc02c0914a879b0955841c7adee6_190)</u> | <u>[61](#i6b5bcc02c0914a879b0955841c7adee6_190)</u> |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**PART I. FINANCIAL INFORMATION**

**Item 1. *Condensed Consolidated Financial Statements***

**COTY INC. & SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(In millions, except per share data**)

**(Unaudited**)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| **Net revenues** | $**1523.6** | $**1578.2** | $**2913.6** | $**2949.9** |
| Cost of sales | 525.3 | 561.1 | 1026.6 | 1065.9 |
| **Gross profit** | **998.3** | **1017.1** | **1887.0** | **1884.0** |
| Selling, general and administrative expenses | 754.3 | 718.9 | 1425.0 | 1495.2 |
| Amortization expense | 47.6 | 51.4 | 94.9 | 108.4 |
| Restructuring costs | (2.9) | (4.1) | (4.1) | 8.3 |
| Acquisition- and divestiture-related costs |  | 6.9 |  | 10.9 |
| **Operating income** | **199.3** | **244.0** | **371.2** | **261.2** |
| Interest expense, net | 61.0 | 60.9 | 126.9 | 120.7 |
| Other income, net | (141.9) | (126.2) | (240.1) | (512.3) |
| **Income from continuing operations before income taxes** | **280.2** | **309.3** | **484.4** | **652.8** |
| Provision for income taxes on continuing operations | 38.8 | 49.4 | 108.5 | 164.0 |
| **Net income from continuing operations** | **241.4** | **259.9** | **375.9** | **488.8** |
| **Net income from discontinued operations** |  | 3.8 |  | 3.8 |
| **Net income** | **241.4** | **263.7** | **375.9** | **492.6** |
| Net loss attributable to noncontrolling interests | (1.4) | (0.9) | (1.4) | (1.4) |
| Net income attributable to redeemable noncontrolling interests | 4.5 | 3.2 | 10.4 | 6.6 |
| **Net income attributable to Coty Inc.** | $**238.3** | $**261.4** | $**366.9** | $**487.4** |
| **Amounts attributable to Coty Inc.** |  |  |  |  |
| Net income from continuing operations | 238.3 | 257.6 | 366.9 | 483.6 |
| Convertible Series B Preferred Stock dividends | (3.3) | (68.7) | (6.6) | (191.7) |
| Net income from continuing operations attributable to common stockholders | 235.0 | 188.9 | 360.3 | 291.9 |
| Net income from discontinued operations |  | 3.8 |  | 3.8 |
| **Net income attributable to common stockholders** | $**235.0** | $**192.7** | $**360.3** | $**295.7** |
| **Earnings per common share:** |  |  |  |  |
| Earnings from continuing operations per common share - basic | $0.28 | $0.23 | $0.43 | $0.36 |
| Earnings from continuing operations per common share - diluted | 0.27 | 0.23 | 0.42 | 0.36 |
| Earnings per common share - basic | 0.28 | 0.23 | 0.43 | 0.36 |
| Earnings per common share - diluted | 0.27 | 0.23 | 0.42 | 0.36 |
| **Weighted-average common shares outstanding:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 850.8 | 829.1 | 846.4 | 803.3 |
| &nbsp;&nbsp;&nbsp;Diluted | 886.8 | 842.7 | 884.5 | 815.1 |

---

See notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**COTY INC. & SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)**

**(In millions)**

**(Unaudited**)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| **Net income** | $**241.4** | $**263.7** | $**375.9** | $**492.6** |
| **Other comprehensive income (loss):** |  |  |  |  |
| Foreign currency translation adjustment | 219.0 | (107.7) | (45.1) | (250.8) |
| Net unrealized derivative gain (loss) on cash flow hedges, net of taxes of $1.2 and $(1.8), and $0.7 and $(3.4) during the three and six months ended, respectively | (3.9) | 5.5 | (3.0) | 9.9 |
| Pension and other post-employment benefits adjustment, net of tax of $(0.8) and $0.0, and $0.0 and $0.0 during the three and six months ended, respectively | 1.5 | 1.8 | (1.7) | 2.3 |
| Total other comprehensive income (loss), net of tax | 216.6 | (100.4) | (49.8) | (238.6) |
| **Comprehensive income** | **458.0** | **163.3** | **326.1** | **254.0** |
| **Comprehensive income attributable to noncontrolling interests:** |  |  |  |  |
| Net loss | (1.4) | (0.9) | (1.4) | (1.4) |
| Foreign currency translation adjustment | 0.3 | (0.1) | 0.3 | (0.3) |
| Total comprehensive loss attributable to noncontrolling interests | (1.1) | (1.0) | (1.1) | (1.7) |
| **Comprehensive income attributable to redeemable noncontrolling interests:** |  |  |  |  |
| Net income | 4.5 | 3.2 | 10.4 | 6.6 |
| Foreign currency translation adjustment | 0.3 |  | 0.1 |  |
| Total comprehensive income attributable to noncontrolling interests | 4.8 | 3.2 | 10.5 | 6.6 |
| **Comprehensive income attributable to Coty Inc.** | $**454.3** | $**161.1** | $**316.7** | $**249.1** |

---

See notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**COTY INC. & SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(In millions, except per share data**)

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| **ASSETS** | | |
| **Current assets:** | | |
| Cash and cash equivalents | $280.8 | $233.3 |
| Restricted cash | 31.5 | 30.5 |
| Trade receivables—less allowances of $30.9 and $53.4, respectively | 433.8 | 364.6 |
| Inventories | 718.2 | 661.5 |
| Prepaid expenses and other current assets | 442.0 | 392.0 |
| **Total current assets** | **1906.3** | **1681.9** |
| Property and equipment, net | 688.7 | 715.5 |
| Goodwill | 3920.3 | 3914.7 |
| Other intangible assets, net | 3848.0 | 3902.8 |
| Equity investments | 1050.6 | 842.6 |
| Operating lease right-of-use assets | 301.5 | 320.9 |
| Deferred income taxes | 622.5 | 651.8 |
| Other noncurrent assets | 116.7 | 85.9 |
| **TOTAL ASSETS** | $**12454.6** | $**12116.1** |
| **LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY** |  |  |
| **Current liabilities:** |  |  |
| Accounts payable | $1489.7 | $1268.3 |
| Accrued expenses and other current liabilities | 1179.7 | 1097.1 |
| Short-term debt and current portion of long-term debt | 68.1 | 23.0 |
| Current operating lease liabilities | 61.0 | 67.8 |
| Income and other taxes payable | 117.1 | 109.4 |
| **Total current liabilities** | **2915.6** | **2565.6** |
| Long-term debt, net | 4014.0 | 4409.1 |
| Long-term operating lease liabilities | 265.2 | 282.2 |
| Pension and other post-employment benefits | 295.7 | 292.2 |
| Deferred income taxes | 723.7 | 669.0 |
| Other noncurrent liabilities | 306.7 | 340.0 |
| **Total liabilities** | **8520.9** | **8558.1** |
| **COMMITMENTS AND CONTINGENCIES (See Note 19)** |  |  |
| **CONVERTIBLE SERIES B PREFERRED STOCK,** $0.01 par value; 1.0 shares authorized; 0.1 and 0.1 issued and outstanding at December 31, 2022 and June 30, 2022, respectively | **142.4** | **142.4** |
| **REDEEMABLE NONCONTROLLING INTERESTS** | **69.7** | **69.8** |
| **EQUITY:** |  |  |
| Preferred Stock, $0.01 par value; 20.0 shares authorized, 1.5 issued and outstanding at December 31, 2022 and June 30, 2022 |  |  |
| Class A Common Stock, $0.01 par value; 1,250.0 shares authorized, 918.9 and 905.5 issued and 852.5 and 839.2 outstanding at December 31, 2022 and June 30, 2022, respectively | 9.1 | 9.0 |
| Additional paid-in capital | 10865.9 | 10805.8 |
| Accumulated deficit | (5129.2) | (5496.1) |
| Accumulated other comprehensive loss | (768.1) | (717.9) |
| Treasury stock—at cost, shares: 66.4 and 66.3 at December 31, 2022 and June 30, 2022, respectively | (1446.3) | (1446.3) |
| **Total Coty Inc. stockholders' equity** | **3531.4** | **3154.5** |
| **Noncontrolling interests** | **190.2** | **191.3** |
| **Total equity** | **3721.6** | **3345.8** |
| **TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY** | $**12454.6** | $**12116.1** |

---

See notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**COTY INC. & SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF EQUITY**

**For the Three and Six Months Ended December 31, 2022** 

**(In millions, except per share data)**

**(Unaudited)**

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Class A<br>Common Stock** | **Class A<br>Common Stock** | **Additional<br>Paid-in Capital** | **(Accumulated Deficit)** | **Accumulated Other Comprehensive (Loss) Income** | **Treasury Stock** | **Treasury Stock** | **Total Coty Inc.<br>Stockholders' Equity** | **Noncontrolling Interests** | **Total Equity** | **Redeemable<br>Noncontrolling Interests** | **Convertible Series B Preferred Stock** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Additional<br>Paid-in Capital** | **(Accumulated Deficit)** | **Accumulated Other Comprehensive (Loss) Income** | **Shares** | **Amount** | **Total Coty Inc.<br>Stockholders' Equity** | **Noncontrolling Interests** | **Total Equity** | **Redeemable<br>Noncontrolling Interests** | **Convertible Series B Preferred Stock** |
| **BALANCE—July 1, 2022** | **1.5** | $**—** | **905.5** | $**9.0** | $**10805.8** | $**(5496.1)** | $**(717.9)** | **66.3** | $**(1446.3)** | $**3154.5** | $**191.3** | $**3345.8** | $**69.8** | $**142.4** |
| Reacquired Class A Common Stock for employee taxes |  |  |  |  |  |  |  | 0.1 |  |  |  |  |  |  |
| Exercise of employee stock options and restricted stock units |  |  | 10.2 |  |  |  |  |  |  |  |  |  |  |  |
| Shares withheld for employee taxes |  |  |  |  | (1.1) |  |  |  |  | (1.1) |  | (1.1) |  |  |
| Share-based compensation expense |  |  |  |  | 31.4 |  |  |  |  | 31.4 |  | 31.4 |  |  |
| Dividends accrued- Convertible Series B Preferred Stock |  |  |  |  | (3.3) |  |  |  |  | (3.3) |  | (3.3) |  | 3.3 |
| Dividends paid - Convertible Series B Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  | (3.3) |
| Net (loss) income |  |  |  |  |  | 128.6 |  |  |  | 128.6 |  | 128.6 | 5.9 |  |
| Other comprehensive loss |  |  |  |  |  |  | (266.2) |  |  | (266.2) |  | (266.2) | (0.2) |  |
| Adjustment of redeemable noncontrolling interests to redemption value |  |  |  |  | 6.2 |  |  |  |  | 6.2 |  | 6.2 | (6.2) |  |
| Equity investment contribution for share-based compensation |  |  |  |  | 1.7 |  |  |  |  | 1.7 |  | 1.7 |  |  |
| **BALANCE—September 30, 2022** | **1.5** | $**—** | **915.7** | $**9.0** | $**10840.7** | $**(5367.5)** | $**(984.1)** | **66.4** | $**(1446.3)** | $**3051.8** | $**191.3** | $**3243.1** | $**69.3** | $**142.4** |
| Exercise of employee stock options and restricted stock units |  |  | 3.2 | 0.1 | (0.1) |  |  |  |  |  |  |  |  |  |
| Shares withheld for employee taxes |  |  |  |  | (10.5) |  |  |  |  | (10.5) |  | (10.5) |  |  |
| Share-based compensation expense |  |  |  |  | 33.6 |  |  |  |  | 33.6 |  | 33.6 |  |  |
| Changes in dividends accrued |  |  |  |  | 0.1 |  |  |  |  | 0.1 |  | 0.1 |  |  |
| Dividends accrued- Convertible Series B Preferred Stock |  |  |  |  | (3.3) |  |  |  |  | (3.3) |  | (3.3) |  | 3.3 |
| Dividends paid - Convertible Series B Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  | (3.3) |
| Net income (loss) |  |  |  |  |  | 238.3 |  |  |  | 238.3 | (1.4) | 236.9 | 4.5 |  |
| Other comprehensive loss |  |  |  |  |  |  | 216.0 |  |  | 216.0 | 0.3 | 216.3 | 0.3 |  |
| Adjustment of redeemable noncontrolling interests to redemption value |  |  |  |  | 4.4 |  |  |  |  | 4.4 |  | 4.4 | (4.4) |  |
| Equity investment contribution for share-based compensation |  |  |  |  | 1.0 |  |  |  |  | 1.0 |  | 1.0 |  |  |
| **BALANCE—December 31, 2022** | **1.5** | $**—** | **918.9** | $**9.1** | $**10865.9** | $**(5129.2)** | $**(768.1)** | **66.4** | $**(1446.3)** | $**3531.4** | $**190.2** | $**3721.6** | $**69.7** | $**142.4** |

---

See notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**COTY INC. & SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF EQUITY**

**For the Three and Six Months Ended December 31, 2021** 

**(In millions, except per share data)**

**(Unaudited)**

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Class A**<br>**Common Stock** | **Class A**<br>**Common Stock** | **Additional**<br>**Paid-in Capital** | **(Accumulated Deficit)** | **Accumulated Other Comprehensive (Loss) Income** | **Treasury Stock** | **Treasury Stock** | **Total Coty Inc.**<br>**Stockholders' Equity** | **Noncontrolling Interests** | **Total Equity** | **Redeemable**<br>**Noncontrolling Interests** | **Convertible Series B Preferred Stock** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br>**Paid-in Capital** | **(Accumulated Deficit)** | **Accumulated Other Comprehensive (Loss) Income** | **Shares** | **Amount** | **Total Coty Inc.**<br>**Stockholders' Equity** | **Noncontrolling Interests** | **Total Equity** | **Redeemable**<br>**Noncontrolling Interests** | **Convertible Series B Preferred Stock** |
| **BALANCE—July 1, 2021** | **1.5** | $**—** | **832.3** | $**8.3** | $**10376.2** | $**(5755.6)** | $**(321.9)** | **66.3** | $**(1446.3)** | $**2860.7** | $**201.5** | $**3062.2** | $**84.1** | $**1036.3** |
| Exercise of employee stock options and restricted stock units |  |  | 51.0 |  |  |  |  |  |  |  |  |  |  |  |
| Shares withheld for employee taxes |  |  |  |  | (4.2) |  |  |  |  | (4.2) |  | (4.2) |  |  |
| Share-based compensation expense |  |  |  |  | 107.8 |  |  |  |  | 107.8 |  | 107.8 |  |  |
| Equity Investment contribution for share-based compensation |  |  |  |  | 1.6 |  |  |  |  | 1.6 |  | 1.6 |  |  |
| Changes in dividends accrued |  |  |  |  | 0.5 |  |  |  |  | 0.5 |  | 0.5 |  |  |
| Conversion of Convertible Series B Preferred Stock |  |  |  | 0.5 | 307.4 |  |  |  |  | 307.9 |  | 307.9 |  | (307.9) |
| Reclassification to Mandatorily redeemable Convertible Series B Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  | (394.2) |
| Dividends Accrued - Convertible Series B Preferred Stock |  |  |  |  | (22.7) |  |  |  |  | (22.7) |  | (22.7) |  | 22.7 |
| Deemed Dividends - Conversion of Convertible Series B Preferred Stock |  |  |  |  | (6.7) |  |  |  |  | (6.7) |  | (6.7) |  | 6.7 |
| Deemed Dividends - Exchange Agreement |  |  |  |  | (93.6) |  |  |  |  | (93.6) |  | (93.6) |  | 93.6 |
| Dividends Paid - Convertible Series B Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  | (3.5) |
| Net income (loss) |  |  |  |  |  | 226.0 |  |  |  | 226.0 | (0.5) | 225.5 | 3.4 |  |
| Other comprehensive loss |  |  |  |  |  |  | (138.0) |  |  | (138.0) | (0.2) | (138.2) |  |  |
| Adjustment of redeemable noncontrolling interests to redemption value |  |  |  |  | 4.1 |  |  |  |  | 4.1 |  | 4.1 | (4.1) |  |
| **BALANCE—September 30, 2021** | **1.5** | $**—** | **883.3** | $**8.8** | $**10670.4** | $**(5529.6)** | $**(459.9)** | **66.3** | $**(1446.3)** | $**3243.4** | $**200.8** | $**3444.2** | $**83.4** | $**453.7** |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Class A**<br>**Common Stock** | **Class A**<br>**Common Stock** | **Additional**<br>**Paid-in Capital** | **(Accumulated Deficit)** | **Accumulated Other Comprehensive (Loss) Income** | **Treasury Stock** | **Treasury Stock** | **Total Coty Inc.**<br>**Stockholders' Equity** | **Noncontrolling Interests** | **Total Equity** | **Redeemable**<br>**Noncontrolling Interests** | **Convertible Series B Preferred Stock** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br>**Paid-in Capital** | **(Accumulated Deficit)** | **Accumulated Other Comprehensive (Loss) Income** | **Shares** | **Amount** | **Total Coty Inc.**<br>**Stockholders' Equity** | **Noncontrolling Interests** | **Total Equity** | **Redeemable**<br>**Noncontrolling Interests** | **Convertible Series B Preferred Stock** |
| Exercise of employee stock options and restricted stock units |  |  | (48.2) |  |  |  |  |  |  |  |  |  |  |  |
| Shares withheld for employee taxes |  |  |  |  | (7.1) |  |  |  |  | (7.1) |  | (7.1) |  |  |
| Share-based compensation expense |  |  |  |  | 26.9 |  |  |  |  | 26.9 |  | 26.9 |  |  |
| Equity Investment contribution for share-based compensation |  |  |  |  | (3.0) |  |  |  |  | (3.0) |  | (3.0) |  |  |
| Changes in dividends accrued |  |  |  |  | 0.2 |  |  |  |  | 0.2 |  | 0.2 |  |  |
| Dividends declared - Cash and Other |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Dividends ($0.125 per common share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Conversion of Convertible Series B Preferred Stock |  |  | 69.9 | 0.2 | 121.4 |  |  |  |  | 121.6 |  | 121.6 |  | (121.6) |
| Exchange Transaction |  |  |  |  |  |  |  |  |  |  |  |  |  | (212.7) |
| Dividends Accrued - Convertible Series B Preferred Stock |  |  |  |  | (5.9) |  |  |  |  | (5.9) |  | (5.9) |  | 5.9 |
| Deemed Dividends - Conversion of Convertible Series B Preferred Stock |  |  |  |  | (0.8) |  |  |  |  | (0.8) |  | (0.8) |  | 0.8 |
| Deemed Dividends - Redemption of Convertible Series B Preferred Stock |  |  |  |  | (66.4) |  |  |  |  | (66.4) |  | (66.4) |  | 66.4 |
| Deemed Contributions - Convertible Series B Preferred Stock |  |  |  |  | 4.4 |  |  |  |  | 4.4 |  | 4.4 |  | (4.4) |
| Dividends Paid - Convertible Series B Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  | (45.7) |
| Net income (loss) |  |  |  |  |  | 261.4 |  |  |  | 261.4 | (0.9) | 260.5 | 3.2 |  |
| Other comprehensive income |  |  |  |  |  |  | (100.3) |  |  | (100.3) | (0.1) | (100.4) |  |  |
| Distribution to noncontrolling interests, net |  |  |  |  |  |  |  |  |  |  | (2.7) | (2.7) | (5.8) |  |
| Adjustment of redeemable noncontrolling interests to redemption value |  |  |  |  | (2.9) |  |  |  |  | (2.9) |  | (2.9) | 2.9 |  |
| **BALANCE—December 31, 2021** | **1.5** | $**—** | **905.0** | $**9.0** | $**10737.2** | $**(5268.2)** | $**(560.2)** | **66.3** | $**(1446.3)** | $**3471.5** | $**197.1** | $**3668.6** | $**83.7** | $**142.4** |

---

See notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**COTY INC. & SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

**(In millions)** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| **Net income** | $**375.9** | $**492.6** |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 210.4 | 267.6 |
| &nbsp;&nbsp;&nbsp;Non-cash lease expense | 32.1 | 36.6 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 84.6 | 99.4 |
| &nbsp;&nbsp;&nbsp;(Releases) provision for bad debts | (15.8) | 1.1 |
| &nbsp;&nbsp;&nbsp;Provision for pension and other post-employment benefits | 4.6 | 8.5 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 65.3 | 135.8 |
| &nbsp;&nbsp;&nbsp;Losses (gains) on disposals of long-term assets, net | 4.7 | (91.1) |
| &nbsp;&nbsp;&nbsp;Gain on sale of business in discontinued operations |  | (4.8) |
| &nbsp;&nbsp;&nbsp;Realized and unrealized gains from equity investments, net | (208.0) | (516.9) |
| &nbsp;&nbsp;&nbsp;Foreign exchange effects | 24.8 | (9.9) |
| &nbsp;&nbsp;&nbsp;Deferred financing fees write-offs | 0.8 | 6.7 |
| &nbsp;&nbsp;&nbsp;Unrealized gains on forward repurchase contracts, net | (19.4) |  |
| &nbsp;&nbsp;&nbsp;Other | 12.8 | 9.3 |
| Change in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Trade receivables | (45.7) | (188.7) |
| &nbsp;&nbsp;&nbsp;Inventories | (55.3) | 40.2 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (55.2) | (101.5) |
| &nbsp;&nbsp;&nbsp;Accounts payable | 227.2 | 257.1 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 75.1 | 271.8 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | (33.5) | (40.2) |
| &nbsp;&nbsp;&nbsp;Income and other taxes payable | 12.2 | 46.9 |
| &nbsp;&nbsp;&nbsp;Other noncurrent assets | (13.3) | (4.4) |
| &nbsp;&nbsp;&nbsp;Other noncurrent liabilities | (38.9) | 18.6 |
| **Net cash provided by operating activities** | **645.4** | **734.7** |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| Capital expenditures | (102.1) | (86.0) |
| Proceeds from sale of long-term assets and license terminations | 56.9 | 126.5 |
| Proceeds from contingent consideration from sale of discontinued business |  | 34.0 |
| **Net cash (used in) provided by investing activities** | **(45.2)** | **74.5** |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| Proceeds from revolving loan facilities | 612.0 | 444.3 |
| Repayments of revolving loan facilities | (806.1) | (1114.7) |
| Proceeds from issuance of other long-term debt |  | 500.0 |
| Repayments of term loans and other long-term debt | (188.6) | (212.2) |
| Dividend payments on Class A Common Stock and Class B Preferred Stock | (7.1) | (50.4) |
| Net payments of foreign currency contracts | (133.5) | (50.8) |
| Purchase of remaining mandatorily redeemable noncontrolling interest |  | (7.1) |
| Distributions to noncontrolling interests, redeemable noncontrolling interests and mandatorily redeemable financial instruments |  | (8.5) |
| Payment of deferred financing fees |  | (37.2) |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

---

| | | |
|:---|:---|:---|
| All other | (13.3) | (10.9) |
| **Net cash used in financing activities** | **(536.6)** | **(547.5)** |
| **EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH** | **(15.1)** | **(9.6)** |
| **NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH** | **48.5** | **252.1** |
| **CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period** | **263.8** | **310.4** |
| **CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period** | $**312.3** | $**562.5** |
| **SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:** |  |  |
| Cash paid during the period for interest | $121.7 | $109.0 |
| Net cash payments for income taxes | 27.3 | 43.5 |
| **SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:** |  |  |
| Accrued capital expenditure additions | $85.3 | $56.3 |
| Redemption of Series B Preferred Stock in exchange for Wella Equity Investment |  | 603.3 |
| Conversion of Series B Preferred Stock into Class A Common Stock |  | 429.5 |
| Non-cash Series B Preferred Stock dividends and deemed dividends (contributions) |  | (1.1) |

---

See notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**COTY INC. & SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**($ in millions, except per share data)**

**(Unaudited)**

**1. DESCRIPTION OF BUSINESS** 

Coty Inc. and its subsidiaries (collectively, the "Company" or "Coty") manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands.

The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word "fiscal" refers to the fiscal year ended June 30 of that year. For example, references to "fiscal 2023" refer to the fiscal year ending June 30, 2023. When used in this Quarterly Report on Form 10-Q, the term "includes" and "including" means, unless the context otherwise indicates, including without limitation.

The Company's sales generally increase during the second fiscal quarter as a result of increased demand associated with the winter holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company's customers may also result in variability.

**2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation**

The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and include the Company's consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company's Consolidated Financial Statements as of and for the year ended June 30, 2022. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three and six months ended December 31, 2022 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2023. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States ("U.S.") dollars, unless otherwise indicated.

**Restricted Cash**

Restricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse. As of December 31, 2022 and June 30, 2022, the Company had restricted cash of $31.5 and $30.5, respectively, included in Restricted cash in the Condensed Consolidated Balance Sheets. The Restricted cash balance as of December 31, 2022 primarily provides collateral for certain bank guarantees on rent, customs and duty accounts and also consists of collections on factored receivables that remain unremitted to the factor as of December 31, 2022. Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows.

**Equity Investments**

The Company elected the fair value option to account for its investment in Rainbow JVCO LTD and subsidiaries (together, "Wella" or the "Wella Company") to align with the Company's strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value hierarchy because the Company estimates the fair value of the investment using a combination of the income approach, the market approach and private transactions, when applicable. Changes in the fair value of equity investment under the fair value option are recorded in Other income, net within the Condensed Consolidated Statements of Operations (see Note 8—Equity Investments).

**Use of Estimates**

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of acquired assets and liabilities associated with acquisitions, the fair value of equity investments, the

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

assessment of goodwill, other intangible assets and long-lived assets for impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the Condensed Consolidated Financial Statements in future periods.

**Tax Information**

The effective income tax rate for the three and six months ended December 31, 2022 and 2021 was 13.8% and 16.0%, respectively, and 22.4% and 25.1%, respectively. The change in the effective tax rate for the three and six months ended December 31, 2022, as compared with the three and six months ended December 31, 2021, was primarily due to foreign exchange loss recognized on the current year repatriation of funds that were previously taxed as part of the Tax Cuts and Jobs Act of 2017 and the larger nondeductible executive stock compensation in the prior period.

The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to the Company's unrealized tax benefits ("UTBs") and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes.

As of December 31, 2022 and June 30, 2022, the gross amount of UTBs was $237.9 and $251.6, respectively. As of December 31, 2022, the total amount of UTBs that, if recognized, would impact the effective income tax rate is $156.8. As of December 31, 2022 and June 30, 2022, the liability associated with UTBs, including accrued interest and penalties, was $184.6 and $191.8, respectively, which was recorded in Income and other taxes payable and Other noncurrent liabilities in the Condensed Consolidated Balance Sheets. The total interest and penalties recorded in the Condensed Consolidated Statements of Operations related to UTBs was $0.1 and $(1.0) for the three months ended December 31, 2022 and 2021, respectively, and $1.4 and $(0.3) for the six months ended December 31, 2022 and 2021, respectively. The total gross accrued interest and penalties recorded in the Condensed Consolidated Balance Sheets as of December 31, 2022 and June 30, 2022 was $27.8 and $26.4, respectively. On the basis of the information available as of December 31, 2022, it is reasonably possible that a decrease of up to $7.5 in UTBs may occur within twelve months as a result of projected resolutions of global tax examinations and a potential lapse of the applicable statutes of limitations.

**Russia Market Exit**

In connection with the Company's Board of Director's decision to wind down operations in Russia, the Company recognized total pre-tax gains in the Condensed Consolidated Statements of Operations of $16.8 and $15.7, respectively, in the three and six months ended December 31, 2022. These amounts are primarily related to a bad debt accrual release due to better than expected collections.

The Company incurred nil of income tax charges associated with the decision to exit Russia in the three and six months ended December 31, 2022.

The Company anticipates incurring up to $8.0 of additional costs through completion of the wind down. Additionally, management anticipates derecognizing the cumulative translation adjustment balance pertaining to the Russian subsidiary. The Company has substantially completed its commercial activities in Russia. However, the Company anticipates that the process related to the liquidation of the Russian legal entity will take an extended period of time.

**Lacoste Fragrances License Termination**

On December 19, 2022, the Company entered into an agreement with Lacoste S.A.S, Sporloisirs S.A., and Lacoste Alligator S.A., (collectively, "Lacoste") to early terminate the existing Lacoste fragrances licensing agreement, effective June 30, 2023. In exchange, Lacoste has agreed to make termination payments to the Company. During the second quarter of fiscal 2023, Lacoste advanced to the Company a portion of the termination payment totaling €52.5 million (approximately $55.6). The amount advanced to the Company has been reflected as deferred income, within Accrued expenses and other current liabilities, until the termination effective date, June 30, 2023.

**Recently Adopted Accounting Pronouncements**

In August 2020, the FASB issued Accounting Standards Update ("ASU") No. 2020-06, *Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity's Own Equity (Subtopic 815-40)*, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if-converted method. The Company adopted this guidance using the modified retrospective method in the first quarter of fiscal year 2023. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

In July 2021, the FASB issued ASU No. 2021-05, *Leases (Topic 842): Lessors-Certain Leases with Variable Lease Payments*, which requires a lessor to classify a lease with variable lease payments that do not depend on an index or rate as an operating lease on the commencement date of the lease if specified criteria are met. The Company adopted this guidance in the first quarter of fiscal year 2023. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

**Recently Issued Accounting Pronouncements**

The FASB issued ASU No. 2020-04, *Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting* in March 2020 and ASU No. 2021-01, *Reference Rate Reform (Topic 848): Scope* in January 2021. The new guidance under these ASUs provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. On December 21, 2022, the FASB issued ASU No. 2022-06, *Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848*, which extended the period of time entities can utilize the reference rate reform relief guidance under ASU No. 2020-04 from December 31, 2022 to December 31, 2024. As of December 31, 2022, the Company has not applied any of the optional expedients or exceptions allowed under these ASUs. The Company does not believe that these ASUs will have a material impact on its consolidated financial position, results of operations or cash flows.

**3**. **DISCONTINUED OPERATIONS**

On June 1, 2020, the Company entered into a definitive agreement with Rainbow UK Bidco Limited ("KKR Bidco") (an affiliate of funds and/or separately managed accounts ("KKR Funds") advised and/or managed by Kohlberg Kravis Roberts & Co. L.P. and its affiliates ("KKR")), for the sale of a majority stake in Coty's Professional and Retail Hair businesses, including the Wella, Clairol, OPI and ghd brands, (together, the "Wella Business"), regarding a strategic transaction for the sale of the Wella Business. The transaction was completed on November 30, 2020 and Coty retained an initial ownership of 40% of the Wella Business. As of December 31, 2022, the Company owned a 25.9% stake in Wella. See Note 8—Equity Investments for additional information.

In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the Wella Business are presented as discontinued operations and have been excluded from both continuing operations and segment results for all periods presented.

For the three and six months ended December 31, 2021, the Company recognized a gain of $4.8 reflecting certain working capital adjustments and a provision of $1.0 in related income tax impact, which are presented as components of Net income from discontinued operations within the Condensed Consolidated Statements of Operation.

**4. SEGMENT REPORTING**

Operating and reportable segments (referred to as "segments") reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the Company's chief operating decision maker ("CODM") in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer ("CEO") as the CODM.

Certain income and shared costs and the results of corporate initiatives are managed by Corporate. Corporate primarily includes stock compensation expense, restructuring and realignment costs, costs related to acquisition, divestiture and license termination activities, and impairments of long-lived assets, goodwill and intangibles that are not attributable to ongoing operating activities of the segments. Corporate costs are not used by the CODM to measure the underlying performance of the segments.

With the exception of goodwill, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill by segment is presented in Note 9—Goodwill and Other Intangible Assets, net.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| **<u>SEGMENT DATA</u>** | **2022** | **2021** | **2022** | **2021** |
| **Net revenues:** |  |  |  |  |
| &nbsp;&nbsp;Prestige | $957.7 | $1008.0 | $1821.2 | $1878.7 |
| &nbsp;&nbsp;Consumer Beauty | 565.9 | 570.2 | 1092.4 | 1071.2 |
| &nbsp;&nbsp;&nbsp;Total | $1523.6 | $1578.2 | $2913.6 | $2949.9 |
| **Operating income (loss):** |  |  |  |  |
| &nbsp;&nbsp;Prestige | 164.4 | 141.6 | 335.0 | 273.7 |
| &nbsp;&nbsp;Consumer Beauty | 49.4 | 43.3 | 81.1 | 54.7 |
| &nbsp;&nbsp;Corporate | (14.5) | 59.1 | (44.9) | (67.2) |
| Total | $199.3 | $244.0 | $371.2 | $261.2 |
| **Reconciliation:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Operating income | 199.3 | 244.0 | 371.2 | 261.2 |
| &nbsp;&nbsp;&nbsp;Interest expense, net | 61.0 | 60.9 | 126.9 | 120.7 |
| &nbsp;&nbsp;&nbsp;Other income, net | (141.9) | (126.2) | (240.1) | (512.3) |
| **Income from continuing operations before income taxes** | $280.2 | $309.3 | $484.4 | $652.8 |

---

Presented below are the percentage of revenues associated with the Company's product categories:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| **<u>PRODUCT CATEGORY</u>** | **2022** | **2021** | **2022** | **2021** |
| &nbsp;&nbsp;&nbsp;Fragrance | 62.2% | 62.7% | 60.8% | 61.3% |
| &nbsp;&nbsp;&nbsp;Color Cosmetics | 25.6 | 26.0 | 26.6 | 27.1 |
| &nbsp;&nbsp;&nbsp;Body Care & Other | 7.9 | 7.1 | 7.8 | 6.9 |
| &nbsp;&nbsp;&nbsp;Skincare | 4.3 | 4.2 | 4.8 | 4.7 |
| **Total** | **100.0%** | **100.0%** | **100.0%** | **100.0%** |

---

**5. ACQUISITION- AND DIVESTITURE-RELATED COSTS**

Acquisition-related costs, which are expensed as incurred, represent non-restructuring costs directly related to acquiring and integrating an entity, for both completed and contemplated acquisitions and can include finder's fees, legal, accounting, valuation, other professional or consulting fees, and other internal costs, which can include compensation related expenses for dedicated internal resources. The Company recognized no acquisition-related costs for the three and six months ended December 31, 2022 and 2021.

Divestiture-related costs, which are expensed as incurred, represent non-restructuring costs directly related to divesting and selling an entity, including partial sales, for both completed and contemplated divestitures. These costs can include legal, accounting, information technology, other professional or consulting fees and other internal costs. Internal costs can include compensation related expenses for dedicated internal resources. Additionally, for divestitures, the Company includes write-offs of assets that are no longer recoverable and contract related costs due to the divestiture. The Company recognized divestiture-related costs of $0.0 and $6.9 for the three months ended December 31, 2022 and 2021, respectively, and $0.0 and $10.9 for the six months ended December 31, 2022 and 2021, respectively. Divestiture-related costs incurred during the three and six months ended December 31, 2021 were primarily related to the strategic transaction with KKR Bidco, for the sale of a majority stake in the Wella Business.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**6. RESTRUCTURING COSTS** 

Restructuring costs for the three and six months ended December 31, 2022 and 2021 are presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Transformation Plan | $(2.9) | $(4.1) | $(4.1) | $8.3 |
| Total | $(2.9) | $(4.1) | $(4.1) | $8.3 |

---

**Transformation Plan**

In connection with the four-year plan announced on July 1, 2019 to drive substantial improvement and optimization in the Company's businesses (the "Turnaround Plan"), the Company has and expects to continue to incur restructuring and related costs. On May 11, 2020, the Company announced an expansion of the Turnaround Plan to further reduce fixed costs, (the "Transformation Plan"). Of the expected costs, the Company has incurred cumulative restructuring charges of $219.2 related to approved initiatives through December 31, 2022, which have been recorded in Corporate.

Over the next fiscal year, the Company expects to incur approximately $4.0 of additional restructuring charges pertaining to the approved actions, primarily related to employee termination benefits.

The following table presents aggregate restructuring charges for the program:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Severance and Employee Benefits** | **Fixed Asset Write-offs** | **Other Exit Costs** | **Total** |
| Fiscal 2020 | $151.2 | $(1.1) | $6.5 | $156.6 |
| Fiscal 2021 | 73.4 | (0.5) | 0.3 | 73.2 |
| Fiscal 2022 | (6.2) |  | (0.3) | (6.5) |
| Fiscal 2023 | (4.1) |  |  | (4.1) |
| Cumulative through December 31, 2022 | $214.3 | $(1.6) | $6.5 | $219.2 |

---

The related liability balance and activity of restructuring costs for the Transformation Plan restructuring costs are presented below:

---

| | | |
|:---|:---|:---|
| | **Severance and Employee Benefits** | **Total** |
| Balance—July 1, 2022 | $55.2 | $55.2 |
| Restructuring charges | 1.5 | 1.5 |
| Payments | (28.6) | (28.6) |
| Changes in estimates | (5.6) | (5.6) |
| Effect of exchange rates | (1.2) | (1.2) |
| Balance—December 31, 2022 | $21.3 | $21.3 |

---

The Company currently estimates that the total remaining accrual of $21.3 will result in cash expenditures of approximately $13.1, $7.7 and $0.5 in fiscal 2023, 2024 and thereafter, respectively.

**7. INVENTORIES**

Inventories as of December 31, 2022 and June 30, 2022 are presented below:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| Raw materials | $212.0 | $171.5 |
| Work-in-process | 11.8 | 13.2 |
| Finished goods | 494.4 | 476.8 |
| Total inventories | $718.2 | $661.5 |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**8. EQUITY INVESTMENTS**

The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| *Equity method investments:* |  |  |
| &nbsp;&nbsp;KKW Holdings <sup>(a)</sup> | $10.6 | $12.6 |
| *Equity investments at fair value:* |  |  |
| &nbsp;&nbsp;Wella <sup>(b)</sup> | 1040.0 | $830.0 |
| Total equity investments | 1050.6 | $842.6 |

---

<sup>(a)</sup>On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company's investment includes basis differences allocated to amortizable intangible assets.

The Company recognized $1.1 and $0.8, respectively, during the three months ended December 31, 2022 and 2021 and $2.0 and $1.4, respectively, during the six months ended December 31, 2022 and 2021 representing its share of the investee's net loss in Other income, net within the Condensed Consolidated Statements of Operations.

<sup>(b)</sup>As of December 31, 2022 and June 30, 2022, the Company's stake in Wella was 25.9%.

For the six months ended December 31, 2022, the impact of the Briogeo acquisition was included for valuation purposes.

The following table presents summarized financial information of the Company's equity method investees for the period ending December 31, 2022. Amounts presented represent combined totals at the investee level and not the Company's proportionate share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** <sup>(a)</sup> |
| **Summarized Statements of Operations information:** |  |  |  |  |
| Net revenues | $660.6 | $744.3 | $1257.2 | $1363.5 |
| Gross profit | 420.3 | 508.4 | 814.9 | 938.1 |
| Operating income | 55.5 | 76.2 | 116.5 | 101.8 |
| Income before income taxes | 0.3 | 49.4 | 20.3 | 56.9 |
| Net (loss) income | (1.5) | 36.5 | 14.5 | 42.0 |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended December 31, 2022. There were no internal movements to or from Level 3 and Level 1 or Level 2 for the period ended December 31, 2022.

---

| | |
|:---|:---|
| **Equity investments at fair value:** | |
| &nbsp;&nbsp;Balance as of June 30, 2022 | $830.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total gains included in earnings | 210.0 |
| &nbsp;&nbsp;Balance as of December 31, 2022 | $1040.0 |

---

**Level 3 significant unobservable inputs sensitivity**

The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of December 31, 2022. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair value** | **Valuation technique** | **Unobservable<br>input** | **Range** |
| &nbsp;&nbsp;Equity investments at fair value | $1040.0 | Discounted cash flows | Discount rate | 10.75% <sup>(a)</sup> |
| &nbsp;&nbsp;Equity investments at fair value | $1040.0 | Discounted cash flows | Growth rate | 1.8% - 7.2% <sup>(a)</sup> |
| &nbsp;&nbsp;Equity investments at fair value | $1040.0 |  |  |  |
| &nbsp;&nbsp;Equity investments at fair value | $1040.0 | Market multiple | Revenue multiple | 2.7x – 3.0x <sup>(b)</sup> |
| &nbsp;&nbsp;Equity investments at fair value | $1040.0 | Market multiple | EBITDA multiple | 12.1x – 14.5x <sup>(b)</sup> |

---

<sup>(a)</sup>The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement.

<sup>(b)</sup>The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies.

**9. GOODWILL AND OTHER INTANGIBLE ASSETS, NET**

**Goodwill**

Goodwill as of December 31, 2022 and June 30, 2022 is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Prestige** | **Consumer Beauty** | **Total** |
| Gross balance at June 30, 2022 | $6220.7 | $1734.1 | $7954.8 |
| &nbsp;&nbsp;Accumulated impairments | (3110.3) | (929.8) | (4040.1) |
| Net balance at June 30, 2022 | $3110.4 | $804.3 | $3914.7 |
| Changes during the period ended December 31, 2022 |  |  |  |
| &nbsp;&nbsp;Foreign currency translation | 5.1 | 0.5 | 5.6 |
| Gross balance at December 31, 2022 | $6225.8 | $1734.6 | $7960.4 |
| &nbsp;&nbsp;Accumulated impairments | (3110.3) | (929.8) | (4040.1) |
| Net balance at December 31, 2022 | $3115.5 | $804.8 | $3920.3 |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**Other Intangible Assets, net**

Other intangible assets, net as of December 31, 2022 and June 30, 2022 are presented below:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| Indefinite-lived other intangible assets | $943.5 | $936.6 |
| Finite-lived other intangible assets, net | 2904.5 | 2966.2 |
| Total Other intangible assets, net | $3848.0 | $3902.8 |

---

The changes in the carrying amount of indefinite-lived other intangible assets are presented below:

---

| | | |
|:---|:---|:---|
| | **Trademarks** | **Total** |
| Gross balance at June 30, 2022 | $1881.5 | $1881.5 |
| &nbsp;&nbsp;&nbsp;Accumulated impairments | (944.9) | (944.9) |
| Net balance at June 30, 2022 | $936.6 | $936.6 |
| Changes during the period ended December 31, 2022 |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation | 6.9 | 6.9 |
| Gross balance at December 31, 2022 | $1888.4 | $1888.4 |
| &nbsp;&nbsp;&nbsp;Accumulated impairments | (944.9) | (944.9) |
| &nbsp;&nbsp;&nbsp;Net balance at December 31, 2022 | $943.5 | $943.5 |

---

Intangible assets subject to amortization are presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Cost** | **Accumulated Amortization** | **Accumulated Impairment** | **Net** |
| **June 30, 2022** | | | | |
| License agreements and collaboration agreements | $3861.9 | $(1302.2) | $(19.6) | $2540.1 |
| Customer relationships | 740.0 | (473.5) | (5.5) | 261.0 |
| Trademarks | 320.5 | (177.1) | (0.5) | 142.9 |
| Product formulations and technology | 83.9 | (61.7) |  | 22.2 |
| Total | $5006.3 | $(2014.5) | $(25.6) | $2966.2 |
| **December 31, 2022** |  |  |  |  |
| License agreements and collaboration agreements | $3907.8 | $(1392.2) | $(19.6) | $2496.0 |
| Customer relationships | 743.3 | (488.7) | (5.5) | 249.1 |
| Trademarks | 320.9 | (183.1) | (0.5) | 137.3 |
| Product formulations and technology | 84.2 | (62.1) |  | 22.1 |
| Total | $5056.2 | $(2126.1) | $(25.6) | $2904.5 |

---

Amortization expense was $47.6 and $51.4 for the three months ended December 31, 2022 and 2021, respectively and $94.9 and $108.4 for the six months ended December 31, 2022 and 2021, respectively.

**10. LEASES**

The Company leases office facilities under non-cancelable operating leases with terms generally ranging between 5 and 25 years. The Company utilizes these leased office facilities for use by its employees in countries in which the Company conducts its business. Leases are negotiated with third parties and, in some instances contain renewal, expansion and termination options. The Company also subleases certain office facilities to third parties when the Company no longer intends to utilize the space. None of the Company's leases restricts the payment of dividends or the incurrence of debt or additional lease obligations, or contain significant purchase options.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

The following chart provides additional information about the Company's operating leases:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
|<br>**Lease Cost:** | **2022** | **2021** | **2022** | **2021** |
| &nbsp;&nbsp;&nbsp;Operating lease cost | $19.3 | $21.2 | $38.5 | $42.1 |
| &nbsp;&nbsp;&nbsp;Short-term lease cost | 0.3 | 0.3 | 0.5 | 0.6 |
| &nbsp;&nbsp;&nbsp;Variable lease cost | 8.2 | 10.0 | 16.8 | 18.9 |
| &nbsp;&nbsp;&nbsp;Sublease income | (3.9) | (5.4) | (7.7) | (10.7) |
| Net lease cost | $23.9 | $26.1 | $48.1 | $50.9 |
| Other information: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Operating cash outflows from operating leases | $(18.7) | $(22.8) | $(40.4) | $(45.3) |
| &nbsp;&nbsp;&nbsp;Right-of-use assets obtained in exchange for lease obligations | $6.2 | $18.6 | $13.8 | $27.0 |
| &nbsp;&nbsp;&nbsp;Weighted-average remaining lease term - real estate |  |  | 7.4 years | 6.3 years |
| &nbsp;&nbsp;&nbsp;Weighted-average discount rate - real estate leases |  |  | 4.07% | 3.49% |

---

Future minimum lease payments for the Company's operating leases are as follows:

---

| | |
|:---|:---|
| **Fiscal Year Ending June 30,** | |
| 2023, remaining | $39.2 |
| 2024 | 67.9 |
| 2025 | 56.9 |
| 2026 | 46.0 |
| 2027 | 38.8 |
| Thereafter | 136.2 |
| Total future lease payments | 385.0 |
| Less: imputed interest | (58.8) |
| Total present value of lease liabilities | 326.2 |
| Current operating lease liabilities | 61.0 |
| Long-term operating lease liabilities | 265.2 |
| Total operating lease liabilities | $326.2 |

---

Table excludes obligations for leases with original terms of twelve months or less, which have not been recognized as ROU assets or liabilities in the Condensed Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**11. DEBT**

The Company's debt balances consisted of the following as of December 31, 2022 and June 30, 2022, respectively:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| Short-term debt | $— | $— |
| **Senior Secured Notes** |  |  |
| &nbsp;&nbsp;&nbsp;2026 Dollar Senior Secured Notes due April 2026 | 900.0 | 900.0 |
| &nbsp;&nbsp;&nbsp;2026 Euro Senior Secured Notes due April 2026 | 746.0 | 731.8 |
| &nbsp;&nbsp;&nbsp;2029 Dollar Senior Secured Notes due January 2029 | 500.0 | 500.0 |
| **2018 Coty Credit Agreement** |  |  |
| &nbsp;&nbsp;&nbsp;2021 Coty Revolving Credit Facility due April 2025 | 75.0 | 273.6 |
| &nbsp;&nbsp;&nbsp;2018 Coty Term B Facility due April 2025 | 1201.0 | 1239.2 |
| **Senior Unsecured Notes** |  |  |
| &nbsp;&nbsp;&nbsp;2026 Dollar Notes due April 2026 | 473.0 | 550.0 |
| &nbsp;&nbsp;&nbsp;2026 Euro Notes due April 2026 | 192.1 | 261.4 |
| Brazilian Credit Facilities | 42.4 | 42.4 |
| Other long-term debt and finance lease obligations | 8.4 | 0.1 |
| Total debt | 4137.9 | 4498.5 |
| Less: Short-term debt and current portion of long-term debt | (68.1) | (23.0) |
| Total Long-term debt | 4069.8 | 4475.5 |
| Less: Unamortized financing fees | (35.4) | (41.8) |
| Less: Discount on long-term debt | (20.4) | (24.6) |
| Total Long-term debt, net | $4014.0 | $4409.1 |

---

**Short-Term Debt**

The Company maintains short-term lines of credit and other short-term debt with financial institutions around the world. As of December 31, 2022, total short-term debt remained constant at nil from June 30, 2022. In addition, the Company had undrawn letters of credit of $13.6 and $14.3, and bank guarantees of $17.8 and $17.2 as of December 31, 2022 and June 30, 2022, respectively.

**Long-Term Debt**

***Recent Developments***

*Cash Tender Offers*

On December 7, 2022, the Company completed its previously announced cash tender offers and redeemed $77.0 of the Company's 2026 Dollar Notes (as defined below) and €69.7 million (approximately $72.2) of the Company's 2026 Euro Notes (as defined below).

*Debt Paydowns*

In December 2022, the Company announced an agreement to early terminate a fragrance license in exchange for a termination payment from the licensor. A portion of the termination payment totaling €52.5 million (approximately $55.6) was advanced to the Company. In accordance with the 2018 Coty Credit Agreement, as amended, the Company utilized a portion of the advance proceeds to pay down €13.5 million (approximately $14.3) and $21.5, respectively, of the outstanding balances of the euro and U.S. dollar portions of the 2018 Term B Facility on December 23, 2022.

***Senior Secured Notes***

On April 21, 2021, the Company issued an aggregate principal amount of $900.0 of 5.00% senior secured notes due 2026 (the "2026 Dollar Senior Secured Notes" and, together with the 2026 Euro Senior Secured Notes and 2029 Dollar Senior Secured Notes, the "Senior Secured Notes"). Coty received gross proceeds of $900.0 in connection with the offering of the 2026 Dollar Senior Secured Notes.

On June 16, 2021, the Company issued an aggregate principal amount of €700.0 million of 3.875% senior secured notes due 2026 (the "2026 Euro Senior Secured Notes") in a private offering. Coty received gross proceeds of €700.0 million in connection with the offering of the 2026 Euro Senior Secured Notes.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

On November 30, 2021, the Company issued an aggregate principal amount of $500.0 of 4.75% senior secured notes due 2029 ("2029 Dollar Senior Secured Notes"). Coty received gross proceeds of $500.0 in connection with the offering of the 2029 Dollar Senior Secured Notes.

Coty used the gross proceeds of the offerings of the Senior Secured Notes to repay a portion of the term loans outstanding under the existing credit facilities and to pay related fees and expenses thereto.

The Senior Secured Notes are senior secured obligations of Coty and are guaranteed on a senior secured basis by each of Coty's wholly-owned domestic subsidiaries that guarantees Coty's obligations under its existing senior secured credit facilities and are secured by first priority liens on the same collateral that secures Coty's obligations under its existing senior secured credit facilities, as described below. The Senior Secured Notes and the guarantees are equal in right of payment with all of Coty's and the guarantors' respective existing and future senior indebtedness and are *pari passu* with all of Coty's and the guarantors' respective existing and future indebtedness that is secured by a first priority lien on the collateral, including the existing senior secured credit facilities, to the extent of the value of such collateral.

***Optional Redemption***

*Applicable Premium*

The indentures governing the Senior Secured Notes specify the Applicable Premium (as defined in the respective indentures) to be paid upon early redemption of some or all of the Senior Secured Notes prior to, and on or after, April 15, 2023 for the 2026 Euro Senior Secured Notes and 2026 Dollar Senior Secured Notes, and January 15, 2025 for the 2029 Dollar Senior Secured Notes (the "Early Redemption Dates").

The Applicable Premium related to the respective Senior Secured Notes on any redemption date and as calculated by the Company is the greater of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)1.0% of the then outstanding principal amount of the respective Senior Secured Notes; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)the excess, if any, of (a) the present value at such redemption date of (i) the redemption price of such respective Senior Secured Notes that would apply if such respective notes were redeemed on the respective Early Redemption Dates, (such redemption price is expressed as a percentage of the principal amount being set forth in the table appearing in the Redemption Pricing section below), plus (ii) all remaining scheduled payments of interest due on the respective Senior Secured Notes to and including the respective Early Redemption Dates, (excluding accrued but unpaid interest, if any, to, but excluding, the redemption date), with respect to each of subclause (i) and (ii), computed using a discount rate equal to the Treasury Rate in the case of the 2026 Dollar Senior Secured Notes and 2029 Dollar Senior Secured Notes, or Bund Rate in the case of the 2026 Euro Senior Secured Notes (both Treasury Rate and Bund Rate as defined in the respective indentures) as of such redemption date plus 50 basis points; over (b) the principal amount of the respective Senior Secured Notes.

*Redemption Pricing*

At any time and from time to time prior to the Early Redemption Dates, the Company may redeem some or all of the respective notes at redemption prices equal to 100% of the respective principal amounts being redeemed plus the Applicable Premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates.

At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below:

---

| | | | |
|:---|:---|:---|:---|
| | **Price** | **Price** | **Price** |
|<br>**For the period beginning** | **2026 Dollar Senior Secured Notes** | **2026 Euro Senior Secured Notes** | **2029 Dollar Senior Secured Notes** |
| **Year** | **April 15,** | **April 15,** | **January 15,** |
| 2023 | 102.500% | 101.938% | N/A |
| 2024 | 101.250% | 100.969% | N/A |
| 2025 | 100.000% | 100.000% | 102.375% |
| 2026 | N/A | N/A | 101.188% |
| 2027 and thereafter | N/A | N/A | 100.000% |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

***2018 Coty Credit Agreement***

On April 5, 2018, the Company entered into a new credit agreement (the "2018 Coty Credit Agreement"), which amended and restated the prior Coty credit agreement. The 2018 Coty Credit Agreement provided for (a) the incurrence by the Company of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the "2018 Coty Term A Facility") and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the "2018 Coty Term B Facility") and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the "Dutch Borrower" and, together with the Company, the "Borrowers"), of a senior secured revolving facility in an aggregate principal amount of $3,250.0 denominated in U.S. dollars, specified alternative currencies or other currencies freely convertible into U.S. dollars and readily available in the London interbank market (the "2018 Coty Revolving Credit Facility") (the 2018 Coty Term A Facility, together with the 2018 Coty Term B Facility and the 2018 Coty Revolving Credit Facility, the "2018 Coty Credit Facilities").

The 2018 Coty Credit Agreement provides that with respect to the 2018 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00.

The obligations of the Company under the 2018 Coty Credit Agreement are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the "Guarantors") and the obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement.

On June 27, 2019, the Company entered into an amendment ("2019 Amendment") to the 2018 Coty Credit Agreement. The 2019 Amendment modified the 2018 Coty Credit Agreement by amending the financial covenants to (i) delay until March 31, 2022 the total net leverage ratio step down from 5.25 to 5.0 (as further described in the *Covenants* section below), (ii) extend the applicable window for certain cost savings add-backs in the calculation of Adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") for purpose of determining the total net leverage ratio, and (iii) amend the determination of the exchange rate to be used for purposes of calculating "Total Indebtedness" (as defined in the 2018 Coty Credit Agreement) for purposes of the total net leverage ratio, and decreasing the total commitments under the revolving credit facility by $500.0 to $2,750.0.

On November 30, 2020, the Company completed the strategic transaction with KKR for the sale of a majority stake in the Wella Business. As part of the transaction, Coty received initial cash proceeds of $2,451.7 for the sale of its 60% stake in the Wella Business and its pro rata share of Wella's return of capital distribution of $448.0, and retained a 40% stake in Wella. In accordance with the 2018 Coty Credit Agreement, as amended, the Company utilized $2,015.5 of the net proceeds to pay down its 2018 Coty Term A and B Facilities on a pro rata basis and reserved a maximum of $500.0 for reinvestment in the business, as defined in the 2018 Coty Credit Agreement, as amended, ("the Reinvestment Balance"). As a result of the prepayments, the outstanding balances of the 2018 Coty Term A and B Facilities were reduced by $1,135.7 and $879.8, respectively.

On September 30, 2021, the Company entered into an amendment to the 2018 Coty Credit Agreement to permanently reduce the existing 2018 Coty Revolving Credit Facility by $700.0 and add a new class of incremental revolving facilities in an aggregate principal amount of $700.0 that matures on April 5, 2025 (the "September 2021 Coty Revolving Credit Facility").

On November 30, 2021, the Company entered into an amendment to the 2018 Coty Credit Agreement that established a new class of senior secured revolving credit facility of $2,000.0 maturing on April 5, 2025 (the "2021 Coty Revolving Credit Facility"), which refinanced and replaced the 2018 Coty Revolving Credit Facility due April 5, 2023 and the September 2021 Coty Revolving Credit Facility due April 5, 2025 (the "2021 Revolver Refinancing"). In connection with the November 30, 2021 amendment to the 2018 Coty Credit Agreement, the Company received consent from the participating banks to eliminate the requirements to utilize or repay the Reinvestment Balance.

In October 2021 and January 2022, the Company completed the sale of certain real estate holdings, and in accordance with the 2018 Coty Credit Agreement, as amended, the Company utilized the proceeds from the sale to pay down a portion of the outstanding balances of the 2018 Coty Term A Facility and 2018 Coty Term B Facility. As a result of the October 2021 prepayments, the outstanding principal balances of the 2018 Coty Term A Facility and the U.S. dollar portion of the 2018 Coty Term B Facility were reduced by €6.2 million (approximately $7.2) and $91.9, respectively. As a result of the January 2022 prepayments, the outstanding principal balances of the euro and U.S. dollar portions of the 2018 Coty Term B Facility were reduced by €13.9 million (approximately $15.7) and $22.3, respectively.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

See the above *Recent Developments* section for information on the prepayments made in December 2022 of the euro and U.S. dollar portions of the 2018 Term B Facility.

***Senior Unsecured Notes***

On April 5, 2018 the Company issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the "2026 Dollar Notes"), €550.0 million of 4.00% senior unsecured notes due 2023 (the "2023 Euro Notes") and €250.0 million of 4.75% senior unsecured notes due 2026 (the "2026 Euro Notes" and, together with the 2023 Euro Notes, the "Euro Notes," and the Euro Notes together with the 2026 Dollar Notes, the "Senior Unsecured Notes") in a private offering.

The Senior Unsecured Notes are senior unsecured debt obligations of the Company and will be *pari passu* in right of payment with all of the Company's existing and future senior indebtedness (including the 2018 Coty Credit Facilities). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors. The Senior Unsecured Notes are senior unsecured obligations of the Company and are effectively junior to all existing and future secured indebtedness of the Company to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness.

The 2026 Dollar and Euro Notes will mature on April 15, 2026. The 2026 Dollar Notes will bear interest at a rate of 6.50% per annum. The 2026 Euro Notes will bear interest at a rate of 4.75% per annum. Interest on the 2026 Dollar and Euro Notes is payable semi-annually in arrears on April 15 and October 15 of each year.

The Company redeemed the 2023 Euro Notes on April 15, 2022.

Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, the Company will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes.

The Senior Unsecured Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of all or substantially all of the Company's assets and certain merger or consolidation transactions. The Senior Unsecured Notes also provide for customary events of default.

See the above *Recent Developments* section for information on the prepayments made in December 2022 of the 2026 Dollar and Euro Notes.

***Deferred Financing Costs and Original Issue Discounts***

The Company wrote off unamortized deferred issuance fees of $0.7 and original issue debt discounts of $0.1 during the three and six months ended December 31, 2022 and wrote off $4.5 and $5.1, respectively, of unamortized deferred issuance fees and $1.6 of original issue debt discounts during the three and six months ended December 31, 2021, which were recorded in Other income, net in the Condensed Consolidated Statement of Operations. Additionally, during the three and six months ended December 31, 2021, the Company capitalized original issue debt discounts of $20.0 and $27.0, respectively, and deferred issuance fees of $8.3 and $8.4, respectively.

***Scheduled Amortization***

The Company makes quarterly payments of 0.25%, of the initial aggregate principal amounts of the 2018 Coty Term B Facility. The remaining balance of the initial aggregate principal amount of the 2018 Coty Term B Facility will be payable on the maturity date of the facility.

*Interest*

The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company's option, either:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)LIBOR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Alternate base rate ("ABR") plus the applicable margin.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

In the case of the 2021 Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below:

---

| | | | |
|:---|:---|:---|:---|
| Pricing Tier | Total Net Leverage Ratio: | LIBOR plus: | Alternative Base Rate Margin: |
| 1.0 | Greater than or equal to 4.75:1 | 2.000% | 1.000% |
| 2.0 | Less than 4.75:1 but greater than or equal to 4.00:1 | 1.750% | 0.750% |
| 3.0 | Less than 4.00:1 but greater than or equal to 2.75:1 | 1.500% | 0.500% |
| 4.0 | Less than 2.75:1 but greater than or equal to 2.00:1 | 1.250% | 0.250% |
| 5.0 | Less than 2.00:1 but greater than or equal to 1.50:1 | 1.125% | 0.125% |
| 6.0 | Less than 1.50:1 | 1.000% | —% |

---

---

| | | | |
|:---|:---|:---|:---|
| Pricing Tier | Debt Ratings S&P/Moody's: | LIBOR plus: | Alternative Base Rate Margin: |
| 5.0 | Less than BB+/Ba1 | 2.000% | 1.000% |
| 4.0 | BB+/Ba1 | 1.750% | 0.750% |
| 3.0 | BBB-/Baa3 | 1.500% | 0.500% |
| 2.0 | BBB/Baa2 | 1.250% | 0.250% |
| 1.0 | BBB+/Baa1 or higher | 1.125% | 0.125% |

---

In the case of the U.S. dollar portion of the 2018 Coty Term B Facility, the applicable margin means 2.25% per annum, in the case of LIBOR loans, and 1.25% per annum, in the case of ABR loans. In the case of the euro portion of the 2018 Coty Term B Facility, the applicable margin means 2.50% per annum, in the case of EURIBOR loans. In no event will LIBOR be deemed to be less than 0.00% per annum.

**Fair Value of Debt**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2022** | **December 31, 2022** | **June 30, 2022** | **June 30, 2022** |
| | **Carrying<br>Amount** | **Fair<br>Value** | **Carrying<br>Amount** | **Fair<br>Value** |
| Senior Secured Notes | $2146.0 | $2007.5 | $2131.8 | $1914.1 |
| 2018 Coty Credit Agreement | 1276.0 | 1245.7 | 1512.8 | 1451.5 |
| Senior Unsecured Notes | 665.1 | 636.8 | 811.4 | 733.5 |
| Brazilian Credit Facilities | 42.4 | 44.5 | 42.4 | 48.2 |

---

The Company uses the market approach to value its debt instruments. The Company obtains fair values from independent pricing services or utilizes the USD LIBOR curve to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized as Level 2 in the fair value hierarchy.

**Debt Maturities Schedule**

Aggregate maturities of the Company's long-term debt, including the current portion of long-term debt and excluding finance lease obligations as of December 31, 2022, are presented below:

---

| | |
|:---|:---|
| **Fiscal Year Ending June 30,** | |
| 2023, remaining | $11.5 |
| 2024 | 65.5 |
| 2025 | 1241.4 |
| 2026 | 2311.1 |
| 2027 |  |
| Thereafter | 500.0 |
| Total | $4129.5 |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**Covenants**

The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period.

---

| | |
|:---|:---|
| **Quarterly Test Period Ending** | **Total Net Leverage Ratio** <sup>(a)</sup>  |
| December 31, 2022 | 4.25 to 1.00 |
| March 31, 2023 through April 5, 2025 | 4.00 to 1.00 |

---

<sup>(a)</sup> Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended.

In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement, as amended), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which the Company's Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period.

As of December 31, 2022, the Company was in compliance with all covenants contained within the 2018 Coty Credit Agreement, as amended.

**12. INTEREST EXPENSE, NET** 

Interest expense, net for the three and six months ended December 31, 2022 and 2021, respectively, is presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Interest expense | $65.0 | $61.7 | $122.6 | $124.5 |
| Foreign exchange losses (gains), net of derivative contracts | 2.1 | (0.2) | 14.0 | (2.4) |
| Interest income | (6.1) | (0.6) | (9.7) | (1.4) |
| Total interest expense, net | $61.0 | $60.9 | $126.9 | $120.7 |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**13. EMPLOYEE BENEFIT PLANS**

The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
| | **Pension Plans** | **Pension Plans** | **Pension Plans** | **Pension Plans** | **Other Post-<br>Employment Benefits** | **Other Post-<br>Employment Benefits** | | |
| | **U.S.** | **U.S.** | **International** | **International** | **Other Post-<br>Employment Benefits** | **Other Post-<br>Employment Benefits** | **Total** | **Total** |
| | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Service cost |  |  | 1.2 | 2.3 | 0.2 | 0.2 | 1.4 | 2.5 |
| Interest cost | 0.2 | 0.1 | 2.7 | 1.6 | 0.4 | 0.3 | 3.3 | 2.0 |
| Expected return on plan assets |  |  | (0.9) | (1.1) |  |  | (0.9) | (1.1) |
| Amortization of prior service credit |  |  |  |  | (0.1) | (0.1) | (0.1) | (0.1) |
| Amortization of net (gain) loss | (0.7) | 0.1 | (0.2) | (0.1) | (0.5) |  | (1.4) |  |
| Settlement loss recognized |  |  |  | 1.3 |  |  |  | 1.3 |
| Curtailment gain recognized |  |  |  | (0.2) |  |  |  | (0.2) |
| Net periodic benefit cost (credit) | (0.5) | 0.2 | 2.8 | 3.8 |  | 0.4 | 2.3 | 4.4 |
|  | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **Pension Plans** | **Pension Plans** | **Pension Plans** | **Pension Plans** | **Other Post-<br>Employment Benefits** | **Other Post-<br>Employment Benefits** |  |  |
|  | **U.S.** | **U.S.** | **International** | **International** | **Other Post-<br>Employment Benefits** | **Other Post-<br>Employment Benefits** | **Total** | **Total** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| Service cost |  |  | 2.4 | 4.7 | 0.4 | 0.4 | 2.8 | 5.1 |
| Interest cost | 0.4 | 0.2 | 5.4 | 3.2 | 0.8 | 0.6 | 6.6 | 4.0 |
| Expected return on plan assets |  |  | (1.8) | (2.2) |  |  | (1.8) | (2.2) |
| Amortization of prior service credit |  |  |  |  | (0.2) | (0.2) | (0.2) | (0.2) |
| Amortization of net (gain) loss | (1.4) | 0.2 | (0.4) | (0.2) | (1.0) |  | (2.8) |  |
| Settlement loss recognized |  |  |  | 2.0 |  |  |  | 2.0 |
| Curtailment gain recognized |  |  |  | (0.2) |  |  |  | (0.2) |
| Net periodic benefit cost (credit) | (1.0) | 0.4 | 5.6 | 7.3 |  | 0.8 | 4.6 | 8.5 |

---

**14. DERIVATIVE INSTRUMENTS**

**Foreign Exchange Risk**

The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions.

In September 2019, the Company entered into cross-currency swap contracts in the notional amount of $550.0 and designated these cross-currency swaps as hedges of its net investment in certain foreign subsidiaries. In September 2020, the Company terminated its existing net investment cross currency swap derivatives in exchange for cash payment of $37.6. The related loss from this termination is included in accumulated other comprehensive income (loss) ("AOCI/(L)") until the sale or substantial liquidation of the underlying net investments.

As of December 31, 2022 and June 30, 2022, the notional amount of the outstanding forward foreign exchange contracts designated as cash flow hedges were $27.9 and $30.0, respectively.

The Company also uses certain derivatives not designated as hedging instruments consisting primarily of foreign currency forward contracts and cross currency swaps to hedge intercompany transactions and foreign currency denominated external debt. Although these derivatives were not designated for hedge accounting, the overall objective of mitigating foreign currency exposure is the same for all derivative instruments. For derivatives not designated as hedging instruments, changes in fair value are recorded in the line item in the Condensed Consolidated Statements of Operations to which the derivative relates. As of

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

December 31, 2022 and June 30, 2022, the notional amounts of these outstanding non-designated foreign currency forward and cross currency forward contracts were $2,106.7 and $2,403.8, respectively.

**Interest Rate Risk**

The Company is exposed to interest rate fluctuations related to its variable rate debt instruments. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in the variable interest rates by entering into offsetting positions through the use of derivative instruments, such as interest rate swap contracts. The interest rate swap contracts result in recognizing a fixed interest rate for the portion of the Company's variable rate debt that was hedged. This will reduce the negative and positive impact of increases in the variable rates over the term of the contracts. Hedge effectiveness of interest rate swap contracts is based on a long-haul hypothetical derivative methodology and includes all changes in value.

As of December 31, 2022 and June 30, 2022, the Company had interest rate swap contracts designated as effective hedges in the notional amount of $800.0. These interest rate swaps are designated and qualify as cash flow hedges and were highly effective.

**Net Investment Hedge**

Foreign currency gains and losses on borrowings designated as a net investment hedge, except ineffective portions, are reported in the cumulative translation adjustment ("CTA") component of AOCI/(L), along with the foreign currency translation adjustments on those investments. As of December 31, 2022 and June 30, 2022, the nominal exposures of foreign currency denominated borrowings designated as net investment hedges were €650.4 million and €289.0 million, respectively. The designated hedge amounts were considered highly effective.

**Forward Repurchase Contracts**

In June and December 2022, the Company entered into certain forward repurchase contracts to start hedging for potential $200.0 and $196.0 share buyback programs, in 2024 and 2025, respectively. These forward repurchase contracts are accounted for at fair value, with changes in the fair value recorded in Other expense (income), net in the Condensed Consolidated Statements of Operations. Refer to Note 15—Equity and Convertible Preferred Stock.

**Derivative and non-derivative financial instruments which are designated as hedging instruments:**

The accumulated gain on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $5.0 and $41.7 as of December 31, 2022 and June 30, 2022, respectively.

The accumulated loss on derivative instruments classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $(37.6) as of December 31, 2022 and June 30, 2022.

The amount of gains and losses recognized in Other comprehensive income (loss) ("OCI") in the Condensed Consolidated Balance Sheets related to the Company's derivative and non-derivative financial instruments which are designated as hedging instruments is presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Gain (Loss) Recognized in OCI** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Foreign exchange forward contracts | $(0.4) | $— | $1.3 | $1.7 |
| Interest rate swap contracts | 0.1 | 2.5 | 1.8 | 1.9 |
| Net investment hedges | (31.4) | 2.2 | (36.7) | 18.9 |

---

The accumulated gain on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $1.3 and $4.3 as of December 31, 2022 and June 30, 2022, respectively. The estimated net gain related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings, net of tax, within the next twelve months is $3.6. As of December 31, 2022, all of the Company's remaining foreign currency forward contracts designated as hedges were highly effective.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company's derivative financial instruments which are designated as hedging instruments is presented below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
|  | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** |
|  | **Net revenues** | **Cost of sales** | **Interest expense, net** | **Net revenues** | **Cost of sales** | **Interest expense, net** |
| **Foreign exchange forward contracts:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amount of gain (loss) reclassified from AOCI into income | $— | $(0.1) | $— | $(0.1) | $0.2 | $— |
| **Interest rate swap contracts:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amount of gain (loss) reclassified from AOCI into income |  |  | 4.9 |  |  | (4.8) |
| **Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** |
|  | **Net revenues** | **Cost of sales** | **Interest expense, net** | **Net revenues** | **Cost of sales** | **Interest expense, net** |
| **Foreign exchange forward contracts:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amount of gain (loss) reclassified from AOCI into income | $— | $(1.6) | $— | $— | $0.2 | $— |
| **Interest rate swap contracts:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amount of gain (loss) reclassified from AOCI into income |  |  | 6.7 |  |  | (9.8) |

---

**Derivatives not designated as hedging:**

The amount of gains and losses related to the Company's derivative financial instruments not designated as hedging instruments is presented below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Condensed Consolidated Statements of Operations<br>Classification of Gain (Loss) Recognized in Operations** | **Condensed Consolidated Statements of Operations<br>Classification of Gain (Loss) Recognized in Operations** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
|  |  | **2022** | **2021** | **2022** | **2021** |
| Foreign exchange contracts | Selling, general and administrative expenses | $(0.1) | $0.1 | $(0.1) | $0.1 |
| Foreign exchange contracts | Interest expense, net | (45.1) | 12.9 | (79.3) | 20.2 |
| Foreign exchange and forward repurchase contracts | Other (expense) income, net | 57.7 | (0.3) | 5.7 | (0.5) |

---

**15. EQUITY AND CONVERTIBLE PREFERRED STOCK** 

**Common Stock**

As of December 31, 2022, the Company's common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. As of December 31, 2022, total authorized shares of Class A Common Stock was 1,250.0 million and total outstanding shares of Class A Common Stock was 852.5 million.

As of December 31, 2022, the Company's largest stockholder was JAB Beauty B.V. (formerly known as Cottage Holdco B.V.), which owned approximately 53% of Coty's outstanding Class A Common Stock. JAB Beauty B.V., a wholly-owned subsidiary of JAB Cosmetics B.V. ("JABC"), is indirectly controlled by Lucresca SE, Agnaten SE and JAB Holdings B.V. ("JAB"). The Company's CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the "Award") on June 30, 2021. On October 29, 2021, JAB Beauty B.V. completed the transfer of 10.0 million shares of Common Stock to Ms. Nabi in connection with her sign-on award of restricted stock units. See Note 16—Share-Based Compensation Plans for additional information.

**Series A and A-1 Preferred Stock**

As of December 31, 2022, total authorized shares of preferred stock are 20.0 million. There are two classes of Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock, both with a par value of $0.01 per share.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

As of December 31, 2022, there were 1.5 million shares of Series A and no shares of Series A-1 Preferred Stock authorized, issued and outstanding. Series A Preferred Stock and Series A-1 Preferred Stock are not entitled to receive any dividends and have no voting rights except as required by law.

As of December 31, 2022, the Company has $0.5 Series A Preferred Stock classified as a liability recorded in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet.

**Convertible Series B Preferred Stock**

On May 11, 2020, the Company entered into an Investment Agreement with KKR Aggregator, relating to the issuance and sale by the Company to KKR Aggregator of up to 1,000,000 shares of the Company's new Convertible Series B Preferred Stock, par value $0.01 per share (the "Series B Preferred Stock"), for an aggregate purchase price of up to $1,000.0, or $1,000 per share (the "Issuance"). The Company completed the issuances and sales of the Series B Preferred Stock on May 26, 2020 and July 31, 2020. On November 16, 2020, KKR Aggregator and affiliated investment funds agreed to sell 146,057 shares of Series B Preferred Stock, to HFS Holdings S.à r.l, that is beneficially owned by Peter Harf, a director of the Company. The transaction closed on August 27, 2021.

As a result of various conversions and exchanges of KKR Aggregator's shares of the Series B Preferred Stock, as of December 31, 2021, KKR has fully redeemed/exchanged all of their Series B Preferred Stock.

Cumulative preferred dividends accrue daily on the Series B Preferred Stock at a rate of 9.0% per year. During the three months ended December 31, 2022 and 2021, the Board of Directors declared dividends on the Series B Preferred Stock of $3.3 and $5.9 and paid accrued dividends of $3.3 and $45.7, respectively. During the six months ended December 31, 2022 and 2021, the Board of Directors declared dividends on the Series B Preferred Stock of $6.6 and $28.6, and paid accrued dividends of $6.6 and $49.3, respectively. As of December 31, 2022 and June 30, 2022, the Series B Preferred Stock had outstanding accrued dividends of $3.3 and $3.3, respectively.

**Treasury Stock**

***Share Repurchase Program***

Since February 2014, the Board has authorized the Company to repurchase its Class A Common Stock under approved repurchase programs. On February 3, 2016, the Board authorized the Company to repurchase up to $500.0 of its Class A Common Stock (the "Incremental Repurchase Program"). Repurchases may be made from time to time at the Company's discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, and general market conditions. For the three and six months ended December 31, 2022, the Company did not repurchase any shares of its Class A Common Stock under the Incremental Repurchase Program. As of December 31, 2022, the Company had authority for $396.8 remaining under the Incremental Repurchase Program.

In June and December 2022, the Company entered into forward repurchase contracts (the "Forward" and together the "Forwards") with three large financial institutions ("Counterparties") to start hedging for potential $200.0 and $196.0 share buyback programs in 2024 and 2025, respectively. In connection with the June and December 2022 Forward transactions, the Company incurred certain execution fees of $2.0 and $2.0, respectively, which were recognized as a premium to the forward price recorded at inception and amortized ratably over the contract periods.

As part of the Forward agreements, the Company will pay interest on the outstanding underlying notional amount of the Forwards held by the Counterparties during the contract periods. The interest rates are variable, based on the United States secured overnight funding rate ("SOFR") plus a spread. The weighted average interest rate plus applicable spread for the June and December 2022 Forward transactions were 7.5% and 8.0%, respectively, as of December 31, 2022.

As part of the June 2022 Forward transaction, two of the Counterparties purchased approximately 27.0 million shares of the Company's Class A Common Stock. In addition, as part of the December 2022 Forward transaction, these two Counterparties purchased approximately 6.7 million shares of the Company's Class A Common Stock. The June and December 2022 Forward agreements require the Company to: (i) repurchase the shares on or before June 6, 2024 and December 15, 2024, respectively, at a price based on the weighted average of the daily volume weighted average price ("VWAP") during the initial acquisition period ("Initial Price"); or (ii) at the Company's option, pay or receive the difference between the Final Price, defined as the weighted average of the daily VWAP during the unwind period as defined in the agreement, and Initial Price of the Forwards.

As part of the December 2022 Forward transaction, the remaining Counterparty purchased approximately 5.6 million shares of the Company's Class A Common Stock. This Forward requires the Company to pay or receive the difference between the Final Price and Initial Price established at inception of the Forward on or before January 15, 2025.

In addition, the Forwards include a provision for a potential true-up in cash upon specified changes in the price of the Company's Class A Common Stock relative to the Initial Price ("Hedge Valuation Adjustment"). Such Hedge Valuation

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

Adjustment shall not result in a termination date or any adjustment of the number of Coty's Class A Common Stock shares purchased by the Counterparties at inception.

In the event the Company declares and pays any cash dividends on its Class A Common Stock, the Forward Counterparties will be entitled to such dividend payments and payable at termination of the Forwards.

Since the Forwards permit a net cash settlement alternative in addition to the physical settlement, the Company accounted for the Forwards initially and subsequently at their fair value, with changes in the fair value recorded in Other income, net in the Condensed Consolidated Statement of Operations.

**Dividends**

On April 29, 2020, the Board of Directors suspended the payment of dividends.

The change in dividends accrued recorded to APIC in the Condensed Consolidated Balance Sheet as of December 31, 2022 was $0.1, which represent dividends no longer expected to vest as a result of forfeitures of outstanding restricted stock units ("RSUs"). In addition to the activity noted above, the Company made a payment of $0.7, of which $0.2 relates to tax, for the previously accrued dividends on RSUs that vested during the six months ended December 31, 2022.

Total accrued dividends on unvested RSUs and phantom units of $1.0 and $0.1 are included in Accrued expenses and other current liabilities and Other noncurrent liabilities, respectively, in the Condensed Consolidated Balance Sheet as of December 31, 2022.

**Accumulated Other Comprehensive Income (Loss)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Foreign Currency Translation Adjustments** | **Foreign Currency Translation Adjustments** | | |
| |<br>**Gain on Cash Flow Hedges** | **Gain (loss) on Net Investment Hedge** | **Other Foreign Currency Translation Adjustments** |<br>**Pension and Other Post-Employment Benefit Plans** <sup>(a)</sup> |<br>**Total** |
| Balance—July 1, 2022 | $4.3 | $4.1 | $(770.8) | $44.5 | $(717.9) |
| Other comprehensive income (loss) before reclassifications | 1.1 | (36.7) | (8.8) | 1.3 | (43.1) |
| Net amounts reclassified from AOCI/(L) | (4.1) |  |  | (3.0) | (7.1) |
| Net current-period other comprehensive loss | (3.0) | (36.7) | (8.8) | (1.7) | (50.2) |
| Balance—December 31, 2022 | $1.3 | $(32.6) | $(779.6) | $42.8 | $(768.1) |

---

<sup>(a)</sup> For the six months ended December 31, 2022, other comprehensive income before reclassifications of $1.3 and net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial losses of $3.0, net of tax of nil.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Foreign Currency Translation Adjustments** | **Foreign Currency Translation Adjustments** | | |
| |<br>**Loss on Cash Flow Hedges** | **(Loss) gain on Net Investment Hedge** | **Other Foreign Currency Translation Adjustments** |<br>**Pension and Other Post-Employment Benefit Plans** |<br>**Total** |
| Balance—July 1, 2021 | $(15.5) | $(32.2) | $(259.3) | $(14.9) | $(321.9) |
| Other comprehensive income (loss) before reclassifications | 2.6 | 18.9 | (269.4) |  | (247.9) |
| Net amounts reclassified from AOCI/(L) | 7.3 |  |  | 2.3 | 9.6 |
| Net current-period other comprehensive income (loss) | 9.9 | 18.9 | (269.4) | 2.3 | (238.3) |
| Balance—December 31, 2021 | $(5.6) | $(13.3) | $(528.7) | $(12.6) | $(560.2) |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**16. SHARE-BASED COMPENSATION PLANS** 

Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Equity plan expense <sup>(a)</sup> | $33.6 | $26.9 | $65.0 | $134.7 |
| Liability plan (income) expense | 0.6 | 0.7 | 0.3 | 1.1 |
| Fringe expense | 1.5 | 2.1 | 1.5 | 2.2 |
| Total share-based compensation expense | $35.7 | $29.7 | $66.8 | $138.0 |

---

<sup>(a)</sup> Equity plan share-based compensation expense of $33.6 and $26.9 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the three months ended December 31, 2022 and 2021, respectively. Equity plan share-based compensation expense of $65.0 and $134.7 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the six months ended December 31, 2022 and 2021, respectively.

As of December 31, 2022, the total unrecognized share-based compensation expense related to stock options, Series A Preferred Stock, restricted stock, and restricted stock units and other share awards is $1.5, $0.0, $4.6 and $137.0, respectively. The unrecognized share-based compensation expense related to stock options, Series A Preferred stock, restricted stock, and restricted stock units and other share awards is expected to be recognized over a weighted-average period of 1.33, 0.00, 2.21 and 1.52 years, respectively.

**Restricted Stock Units and Other Share Awards**

The Company granted 8.3 million and 8.3 million shares of RSUs and other share awards during the three and six months ended December 31, 2022, respectively. The Company recognized share-based compensation expense of $34.5 and $30.3 for the three months ended December 31, 2022 and 2021, respectively, of which $23.6 and $23.2 related to Ms. Nabi's award, as described below. The Company recognized share-based compensation expense of $65.2 and $137.2 for the six months ended December 31, 2022 and 2021, respectively, of which $47.1 and $124.0, respectively, related to Ms. Nabi's award.

The Company's CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the "Award") on June 30, 2021. The Award will vest and settle in 10,000,000 shares of the Company's Class A Common Stock, par value $0.01 per share, on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to her continued employment through each such date. The Company will recognize the share-based compensation expense, on a straight-line basis over the vesting period, based on the fair value on the grant date. The amount of compensation cost recognized at each vesting date must at least equal the portion of the award legally vested.

In connection with this Award, JAB Beauty B.V., the Company's largest stockholder and a wholly-owned subsidiary of JAB Holding Company S.à r.l., agreed, pursuant to an equity transfer agreement, to transfer to Ms. Nabi (either directly or through contributing to the Company) 10,000,000 shares of Class A Common Stock no later than sixty days following the first vesting date. On October 29, 2021, JAB Beauty B.V. completed the transfer of 10,000,000 shares of Class A Common Stock to Ms. Nabi. In the event Ms. Nabi remains employed through the third vesting date, JAB Beauty B.V. has agreed to transfer an additional 5,000,000 shares of Class A Common Stock to Ms. Nabi.

On August 31, 2022, the Company issued 10,000,000 shares of Class A Common Stock to Ms. Nabi in connection with the second vesting of the Award.

**Restricted Stock**

The Company granted 0.4 million and 0.4 million shares of restricted stock, during the three and six months ended December 31, 2022, respectively. The Company recognized share-based compensation expense of $0.7 and $0.3 for the three months ended December 31, 2022 and 2021, respectively, and $1.2 and $0.5 for the six months ended December 31, 2022 and 2021, respectively.

**Series A Preferred Stock and Series A-1 Preferred Stock**

The Company granted no shares of Series A Preferred Stock and no shares of Series A-1 Preferred Stock during the three and six months ended December 31, 2022, respectively. The Company recognized share-based compensation expense (income) of $0.2 and $0.5 for the three months ended December 31, 2022 and 2021, respectively, and $(0.2) and $0.9 for the six months ended December 31, 2022 and 2021, respectively.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**Non-Qualified Stock Options**

The Company granted no non-qualified stock options during the three and six months ended December 31, 2022. The Company recognized share-based compensation expense (income) of $0.3 and $(1.4) for the three months ended December 31, 2022 and 2021, respectively, and $0.6 and $(0.6) for the six months ended December 31, 2022 and 2021, respectively.

**17. NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE**

Reconciliation between the numerators and denominators of the basic and diluted income per share ("EPS") computations is presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| **Amounts attributable to Coty Inc.:** |  |  |  |  |
| **Net income from continuing operations** | $**238.3** | $**257.6** | $**366.9** | $**483.6** |
| Convertible Series B Preferred Stock dividends | (3.3) | (68.7) | (6.6) | (191.7) |
| Net income from continuing operations attributable to common stockholders | 235.0 | 188.9 | 360.3 | 291.9 |
| Net income from discontinued operations, net of tax |  | 3.8 |  | 3.8 |
| **Net income attributable to common stockholders** | $235.0 | $192.7 | $360.3 | $295.7 |
| **Weighted-average common shares outstanding:** |  |  |  |  |
| Weighted-average common shares outstanding—Basic | 850.8 | 829.1 | 846.4 | 803.3 |
| Effect of dilutive stock options and Series A Preferred Stock <sup>(a)</sup> |  |  |  |  |
| Effect of restricted stock and RSUs <sup>(b)</sup> | 12.3 | 13.6 | 14.4 | 11.8 |
| Effect of Convertible Series B Preferred Stock <sup>(c)</sup> | 23.7 |  | 23.7 |  |
| Effect of Forward Repurchase Contracts <sup>(d)</sup> |  |  |  |  |
| Weighted-average common shares outstanding—Diluted | 886.8 | 842.7 | 884.5 | 815.1 |
| **Earnings per common share:** |  |  |  |  |
| Earnings from continuing operations per common share - basic | $0.28 | $0.23 | $0.43 | $0.36 |
| Earnings from continuing operations per common share - diluted <sup>(e)</sup> | 0.27 | 0.23 | 0.42 | 0.36 |
| Earnings per common share - basic | 0.28 | 0.23 | 0.43 | 0.36 |
| Earnings per common share - diluted <sup>(e)</sup> | 0.27 | 0.23 | 0.42 | 0.36 |

---

<sup>(a)</sup> For the three months ended December 31, 2022 and 2021, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 5.8 million and 8.8 million shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the six months ended December 31, 2022 and 2021, outstanding stock options and Series A/A-1 Preferred Stock with purchase or conversion rights to purchase 6.0 million and 10.1 million weighted average shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.

<sup>(b)</sup> For the three months ended December 31, 2022 and 2021, there were nil anti-dilutive RSUs excluded from the computation of diluted EPS. For the six months ended December 31, 2022 and 2021, there were nil and 2.5 million weighted average anti-dilutive RSUs, respectively, excluded from the computation of diluted EPS.

<sup>(c)</sup> For the three months ended December 31, 2022 and 2021, there were nil and 49.6 million weighted average dilutive shares of Convertible Series B Preferred Stock, respectively, excluded from the computation of diluted EPS as their inclusion would be anti-dilutive. For the six months ended December 31, 2022 and 2021, there were nil and 106.4 million weighted average dilutive shares of Convertible Series B Preferred Stock, respectively, excluded from the computation of diluted EPS as their inclusion would be anti-dilutive.

<sup>(d)</sup> For the three and six months ended December 31, 2022, shares for the Forward Repurchase Contracts were excluded from the computation of diluted EPS as Coty is in the position to receive shares from the counterparties and as such their inclusion would be anti-dilutive.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

<sup>(e)</sup> Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans, the convertible Series B Preferred Stock, and the Forward Repurchase Contracts. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock and RSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock and the Forward Repurchase Contracts. The treasury method typically does not adjust the net income attributable to Coty Inc., while the if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $3.3 and $68.7, and to reverse the impact of fair market value (gains)/losses for contracts with the option to settle in shares or cash of $(44.3) and $0.0, respectively, if dilutive, for the three months ended December 31, 2022 and 2021 on net income applicable to common stockholders during the period. The if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $6.6 and $191.7, and to reverse the impact of fair market value (gains)/losses for contracts with the option to settle in shares or cash of $(6.8) and $0.0, respectively, if dilutive, for the six months ended December 31, 2022 and 2021 on net income applicable to common stockholders during the period.

**18. MANDATORILY REDEEMABLE FINANCIAL INTERESTS AND REDEEMABLE NONCONTROLLING INTERESTS**

**Mandatorily Redeemable Financial Interest**

***United Arab Emirates subsidiary***

In July 2021, the Company purchased the remaining 25% noncontrolling interest of a certain subsidiary in the United Arab Emirates from the noncontrolling interest holder for $7.1, pursuant to the related U.A.E. Shareholders Agreement. The termination was effective on December 31, 2020 and immediately prior to the cash payment, the noncontrolling interest balance was recorded as a mandatorily redeemable financial instrument liability.

**Redeemable Noncontrolling Interests**

***Subsidiary in the Middle East***

As of December 31, 2022, the noncontrolling interest holder in the Company's subsidiary in the Middle East had a 25% ownership share. The Company adjusts the redeemable noncontrolling interests ("RNCI") to redemption value at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $69.7 and $69.8 as the RNCI balances as of December 31, 2022 and June 30, 2022, respectively.

**19. COMMITMENTS AND CONTINGENCIES**

**Legal Matters**

The Company is involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to its business, including consumer class or collective actions, personal injury (including asbestos claims related to the Company's talc-based cosmetic products), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, "Legal Proceedings"). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company's securities. However, management's assessment of the Company's current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management's evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities.

*Certain Litigation*. A consolidated stockholder class and derivative action (the "Tender Offer Litigation") concerning the tender offer by JAB Beauty B.V. (the "Cottage Tender Offer") and the Schedule 14D-9 is pending against certain current and former directors of the Company, JAB Holding Company S.à r.l., JAB Holdings B.V., JAB Cosmetics B.V., and JAB Beauty B.V. in the Court of Chancery of the State of Delaware. The Company was named as a nominal defendant. The case, which was filed on May 6, 2019, was captioned Massachusetts Laborers' Pension Fund v. Harf et al., Case No. 2019-0336-AGB. On June 14, 2019, plaintiffs in the consolidated action filed a Verified Amended Class Action and Derivative Complaint ("Amended Complaint"). After defendants responded to the Amended Complaint, on October 21, 2019, plaintiffs filed a Verified Second Amended Class Action and Derivative Complaint (the "Second Amended Complaint"), alleging that the directors and JAB Holding Company S.à r.l., JAB Holdings B.V., JAB Cosmetics B.V., and JAB Beauty B.V. breached their fiduciary duties to the Company's stockholders and breached the Stockholders Agreement. The Second Amended Complaint seeks, among other things, monetary relief. On November 21, 2019, the defendants moved to dismiss certain claims asserted in the Second Amended Complaint, and certain of the director defendants also answered the complaint. On May 7, 2020, plaintiffs stipulated

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

to the dismissal without prejudice of JAB Holding Company S.à r.l. from the action. On August 17, 2020, the court denied the remaining motions to dismiss. As of October 17, 2022, the parties to the Tender Offer Litigation have reached an agreement in principle to resolve the matter, which is not expected to have a material impact on the Company's financial results.

At this time, the Company cannot reasonably estimate a range of loss, if any, not covered by available insurance, that may result given the current status of these lawsuits.

**Brazilian Tax Assessments**

The Company's Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of December 31, 2022 are:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Assessment received** | **Type of assessment** | **Type of Tax** | **Tax period impacted** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Estimated amount, including interest and penalties as of** <br>**December 31, 2022** |
| Mar-18 | State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered | ICMS | 2016-2017 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R$1.1 million (approximately $0.2) |
| Aug-20 | State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered | ICMS | 2017-2019 | R$713.4 million (approximately $134.9) |
| Oct-20 | Federal excise taxes, which the Treasury Office of the Brazil's Internal Revenue Service considers as improperly calculated | IPI | 2016-2017 | R$382.9 million (approximately $72.4) |
| Nov-22 | Federal excise taxes, which the Treasury Office of the Brazil's Internal Revenue Service considers as improperly calculated | IPI | 2018-2019 | R$509.0 million (approximately $96.3) |
| Nov-20 | State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated | ICMS | 2016-2019 | R$207.7 million (approximately $39.3) |
| Jun-21 | State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated | ICMS | 2016-2020 | R$82.0 million (approximately $15.5) |

---

All cases are currently in the administrative process. The Company is seeking favorable administrative decisions on the tax enforcement actions filed by the tax authorities for these assessments. The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable. Due to the fiscal environment in Brazil, the possibility of further tax assessments related to the same or similar matters cannot be ruled out.

**20. RELATED PARTY TRANSACTIONS**

**Relationship with KKR**

On December 22, 2021, the Company entered into an agreement with KKR Bidco related to post-closing adjustments to the purchase consideration for the Wella Business. In relation to this agreement, the Company recognized gains of $12.5 and $26.4, in the three and six months ended December 31, 2022, respectively, which are reported in Other income, net in the Condensed Consolidated Statements of Operations. The unearned portion of amounts advanced to the Company as part of this agreement was $6.9 as of December 31, 2022 and is reflected in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet.

**Wella**

As of December 31, 2022, Coty owned 25.9% of the Wella Company as an equity investment and performs certain services to Wella. Refer to Note 8— Equity Investments.

In connection with the sale of the Wella Business, the Company and Wella entered into a Transitional Services Agreement ("TSA"). Subject to the terms of this TSA, the Company will perform services for Wella in exchange for related service fees. Such services include billing and collecting from Wella customers, certain logistics and warehouse services, as well as other administrative and systems support. The Company and Wella have mutually agreed to end the contracted TSA services on January 31, 2022. The Company and Wella have also entered into other manufacturing and distribution arrangements to facilitate the Wella Business transition in the U.S. and Brazil. TSA fees and other fees earned were $0.7 and $2.0, respectively, for the three months ended December 31, 2022 and $37.1 and $1.6, respectively, for the three months ended December 31, 2021. TSA fees and other fees earned were $1.5 and $4.1, respectively, for the six months ended December 31, 2022 and $70.3 and $3.1, respectively, for the six months ended December 31, 2021. The TSA fees are principally invoiced on a cost plus basis. The TSA fees and other fees were included in Selling, general and administrative expenses and Cost of sales, respectively, in the Company's Condensed Consolidated Statement of Operations.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

The Company also entered into an agreement with Wella to provide management, consulting and financial services to Wella and its direct and indirect divisions, subsidiaries, parent entities and controlled affiliates (in assisting it in the management of its business). Amounts due to the Company pursuant to this arrangement as of December 31, 2022 is $0.3.

As of December 31, 2022, accounts receivable from and accounts payable to Wella of $77.1 and $1.3, respectively, were included in Prepaid expenses and other current assets and Accrued expenses and other current liabilities, respectively, in the Company's Condensed Consolidated Balance Sheets. Additionally, as of December 31, 2022, the Company has accrued $46.0 related to long-term payables due to Wella included in Other noncurrent liabilities in the Company's Condensed Consolidated Balance Sheet.

In accordance with the separation agreement with Wella, Coty shall retain and be solely responsible for any amounts payable to former Coty employees transferred to Wella ("Wella employees"), who participated in the Coty Long-Term Incentive Plan. The Wella employees will continue to participate and vest on the current terms for the remaining vesting period after the separation. As such, Coty will continue to recognize the share-based compensation expense for Wella employees until the existing equity awards reach their vesting date. For the three and six months ended December 31, 2022 and 2021, Coty recorded $1.0 and $(3.0), respectively, and $2.7 and $(1.4) of share-based compensation expense (income) related to Wella employees, which was presented as part of Other income, net in the Condensed Consolidated Statements of Operations.

The Company has certain sublease arrangements with Wella after the sale. The Company reported sublease income from Wella of $2.3 and $4.7, respectively, and $4.7 and $7.1, respectively, for the three and six months ended December 31, 2022 and 2021.

**21. SUBSEQUENT EVENTS**

The Company evaluated the effect of events and transactions subsequent to the condensed consolidated balance sheet date of December 31, 2022 through the date of issuance of the Condensed Consolidated Financial Statements and determined that no subsequent events have occurred that require recognition in the Condensed Consolidated Financial Statements or disclosure in the notes to the Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**Item 2. *Management's Discussion and Analysis of Financial Condition and Results of Operations.***

The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its consolidated subsidiaries, should be read in conjunction with the information contained in the Condensed Consolidated Financial Statements and related notes included elsewhere in this document, and in our other public filings with the Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 ("Fiscal 2022 Form 10-K"). When used in this discussion, the terms "Coty," the "Company," "we," "our," or "us" mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. Also, when used in this Quarterly Report on Form 10-Q, the term "includes" and "including" means, unless the context otherwise indicates, including without limitation. The following report includes certain non-GAAP financial measures. See "Overview—Non-GAAP Financial Measures" for a discussion of non-GAAP financial measures and how they are calculated.

All dollar amounts in the following discussion are in millions of United States ("U.S.") dollars, unless otherwise indicated.

More information about potential risks and uncertainties that could affect our business and financial results is included under the heading "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Quarterly Report on Form 10-Q and other periodic reports we have filed and may file with the SEC from time to time.

**Forward-looking Statements** 

Certain statements in this Form 10-Q are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, strategic planning, targets and outlook for future reporting periods (including the extent and timing of revenue, expense and profit trends and changes in operating cash flows and cash flows from operating activities and investing activities), the wind down of the Company's operations in Russia (including timing and expected impact), the Company's future operations and strategy (including the expected implementation and related impact of its strategic priorities), ongoing and future cost efficiency, optimization and restructuring initiatives and programs, strategic transactions (including their expected timing and impact), expectations and/or plans with respect to joint ventures (including Wella and the timing and size of any related distribution or return of capital), the Company's capital allocation strategy and payment of dividends (including suspension of dividend payments and the duration thereof and any plans to resume cash dividends on common stock or to continue to pay dividends in cash on preferred stock), investments, licenses and portfolio changes, product launches, relaunches or rebranding (including the expected timing or impact thereof), synergies, savings, performance, cost, timing and integration of acquisitions, future cash flows, liquidity and borrowing capacity (including any refinancing or deleveraging activities), timing and size of cash outflows and debt deleveraging, the timing and extent of any future impairments, and synergies, savings, impact, cost, timing and implementation of the Company's ongoing transformation agenda (including operational and organizational structure changes, operational execution and simplification initiatives, fixed cost reductions, and supply chain changes), the impact, cost, timing and implementation of e-commerce and digital initiatives, expected impact, cost, timing and implementation of sustainability initiatives (including progress, plans and goals), the impact of COVID-19, the expected impact of geopolitical risks including the ongoing war in Ukraine on our business operations, sales outlook and strategy, the expected impact of global supply chain challenges and/or inflationary pressures (including as a result of COVID-19 and/or the war in Ukraine) and expectations regarding future service levels, and the priorities of senior management. These forward-looking statements are generally identified by words or phrases, such as "anticipate", "are going to", "estimate", "plan", "project", "expect", "believe", "intend", "foresee", "forecast", "will", "may", "should", "outlook", "continue", "temporary", "target", "aim", "potential", "goal" and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully implement our multi-year transformation agenda and compete effectively in the beauty industry, achieve the benefits contemplated by our strategic initiatives (including revenue growth, cost control, gross margin growth and debt deleveraging) and successfully implement our strategic priorities (including stabilizing our consumer beauty brands through leading innovation and improved execution, accelerating our prestige fragrance brands and ongoing expansion into prestige cosmetics, building a comprehensive skincare portfolio, enhancing our e-commerce and direct-to-consumer ("DTC") capabilities, expanding our presence in China through prestige products and select consumer beauty brands, and establishing Coty as an industry leader in sustainability) in each case within the expected time frame or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly, and the market acceptance of new products, including new products related to Kylie Jenner's or Kim Kardashian West's existing beauty businesses, any relaunched or rebranded products and the anticipated costs and discounting

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

associated with such relaunches and rebrands, and consumer receptiveness to our current and future marketing philosophy and consumer engagement activities (including digital marketing and media);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• use of estimates and assumptions in preparing our financial statements, including with regard to revenue recognition, income taxes (including the expected timing and amount of the release of any tax valuation allowance), the assessment of goodwill, other intangible and long-lived assets for impairments, the market value of inventory, the fair value of the equity investment, and the fair value of acquired assets and liabilities associated with acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of any future impairments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• managerial, transformational, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with the Company's response to COVID-19, our transformation agenda, our global business strategies, the integration of the strategic partnerships with Kylie Jenner and Kim Kardashian West, and future strategic initiatives, and, in particular, our ability to manage and execute many initiatives simultaneously including any resulting complexity, employee attrition or diversion of resources;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the timing, costs and impacts of divestitures and the amount and use of proceeds from any such transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• future divestitures and the impact thereof on, and future acquisitions, new licenses and joint ventures and the integration thereof with, our business, operations, systems, financial data and culture and the ability to realize synergies, manage supply chain challenges and avoid future supply chain and other business disruptions, reduce costs (including through our cash efficiency initiatives), avoid liabilities and realize potential efficiencies and benefits (including through our restructuring initiatives) at the levels and at the costs and within the time frames contemplated or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increased competition, consolidation among retailers, shifts in consumers' preferred distribution and marketing channels (including to digital and Prestige channels), distribution and shelf-space resets or reductions, compression of go-to-market cycles, changes in product and marketing requirements by retailers, reductions in retailer inventory levels and order lead-times or changes in purchasing patterns, impact from COVID-19 on retail revenues, and other changes in the retail, e-commerce and wholesale environment in which we do business and sell our products and our ability to respond to such changes (including our ability to expand our digital, direct-to-consumer and e-commerce capabilities within contemplated timeframes or at all);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our and our joint ventures', business partners' and licensors' abilities to obtain, maintain and protect the intellectual property used in our and their respective businesses, protect our and their respective reputations (including those of our and their executives or influencers) and public goodwill, and defend claims by third parties for infringement of intellectual property rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any change to our capital allocation and/or cash management priorities, including any change in our dividend policy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any unanticipated problems, liabilities or integration or other challenges associated with a past or future acquired business, joint ventures or strategic partnerships, which could result in increased risk or new, unanticipated or unknown liabilities, including with respect to environmental, competition and other regulatory, compliance or legal matters, and specifically in connection with the strategic partnerships with Kylie Jenner and Kim Kardashian West, risks related to the entry into a new distribution channel, the potential for channel conflict, risks of retaining customers and key employees, difficulties of integration (or the risks associated with limiting integration), ability to protect trademarks and brand names, litigation or investigations by governmental authorities, and changes in law, regulations and policies that affect KKW Holdings, LLC's ("KKW Holdings") business or products, including risk that direct selling laws and regulations may be modified, interpreted or enforced in a manner that results in a negative impact to KKW Holdings' business model, revenue, sales force or business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our international operations and joint ventures, including enforceability and effectiveness of our joint venture agreements and reputational, compliance, regulatory, economic and foreign political risks, including difficulties and costs associated with maintaining compliance with a broad variety of complex local and international regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our dependence on certain licenses (especially in the fragrance category) and our ability to renew expiring licenses on favorable terms or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our dependence on entities performing outsourced functions, including outsourcing of distribution functions, and third-party manufacturers, logistics and supply chain suppliers, and other suppliers, including third-party software providers, web-hosting and e-commerce providers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• administrative, product development and other difficulties in meeting the expected timing of market expansions, product launches, re-launches and marketing efforts, including in connection with new products related to Kylie Jenner's or Kim Kardashian West's existing beauty businesses or new products related to Orveda;

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in the demand for our products due to declining or depressed global or regional economic conditions, and declines in consumer confidence or spending, whether related to the economy (such as austerity measures, tax increases, high fuel costs, or higher unemployment), wars, natural or other disasters, weather, pandemics, security concerns, terrorist attacks or other factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect our business, financial performance, operations or products, including the impact of the war in Ukraine and any escalation or expansion thereof, Brexit (and related business or market disruption), recent elections in Brazil, the current U.S. administration and mid-term elections, changes in the U.S. tax code, and recent changes and future changes in tariffs, retaliatory or trade protection measures, trade policies and other international trade regulations in the U.S., the European Union, and Asia and in other regions where we operate, and recent and future changes in sanctions regulations including in connection with the war in Ukraine and any escalation or expansion thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• currency exchange rate volatility and currency devaluation and/or inflation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the number, type, outcomes (by judgment, order or settlement) and costs of current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including product liability cases (including asbestos and talc-related litigation for which indemnities and/or insurance may not be available), distributor or licensor litigation, and compliance, litigation or investigations relating to our joint ventures and strategic partnerships;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to manage seasonal factors and other variability and to anticipate future business trends and needs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of COVID-19 (or future similar events), including demand for the Company's products, illness, quarantines, government actions, facility closures, store closures or other restrictions in connection with the COVID-19 pandemic, and the extent and duration thereof, related impact on our ability to meet customer needs and on the ability of third parties on which we rely, including our suppliers, customers, contract manufacturers, distributors, contractors, commercial banks and joint-venture partners, to meet their obligations to us, in particular collections from customers, and the ability to successfully implement measures to respond to such impacts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disruptions in the availability and distribution of raw materials and components needed to manufacture our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disruptions in operations, sales and in other areas, including due to disruptions in our supply chain, restructurings and other business alignment activities, manufacturing or information technology systems, labor disputes, extreme weather and natural disasters, impact from COVID-19 or similar global public health events, the outbreak of war or hostilities (including the war in Ukraine and any escalation or expansion thereof), the impact of global supply chain challenges, and the impact of such disruptions on our ability to generate profits, stabilize or grow revenues or cash flows, comply with our contractual obligations and accurately forecast demand and supply needs and/or future results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to adapt our business to address climate change concerns and to respond to increasing governmental and regulatory measures relating to environmental, social and governance matters, including expanding mandatory and voluntary reporting, diligence and disclosure, as well as new taxes (including on energy and plastic), and the impact of such measures on our costs, business operations and strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• restrictions imposed on us through our license agreements, credit facilities and senior unsecured bonds or other material contracts, our ability to generate cash flow to repay, refinance or recapitalize debt and otherwise comply with our debt instruments, and changes in the manner in which we finance our debt and future capital needs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increasing dependency on information technology, including as a result of remote working in response to COVID-19, and our ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, including ransomware attacks, costs and timing of implementation and effectiveness of any upgrades or other changes to information technology systems, and the cost of compliance or our failure to comply with any privacy or data security laws (including the European Union General Data Protection Regulation (the "GDPR"), the California Consumer Privacy Act and similar state laws, the Brazil General Data Protection Law, and the China Data Security Law and Personal Information Protection Law) or to protect against theft of customer, employee and corporate sensitive information;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract and retain key personnel and the impact of senior management transitions and organizational structure changes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the distribution and sale by third parties of counterfeit and/or gray market versions of our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of our transformation agenda on our relationships with key customers and suppliers and certain material contracts;

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our relationship with JAB Beauty B.V. (formerly known as Cottage Holdco B.V.), as our majority stockholder, and its affiliates, and any related conflicts of interest or litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our relationship with KKR, whose affiliate KKR Bidco, is an investor in the Wella Business, and any related conflicts of interest or litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• future sales of a significant number of shares by our majority stockholder or the perception that such sales could occur; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors described elsewhere in this document and in documents that we file with the SEC from time to time.

More information about potential risks and uncertainties that could affect our business and financial results is included under the heading "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Quarterly Report on Form 10-Q and other periodic reports we have filed and may file with the SEC from time to time.

All forward-looking statements made in this document are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.

Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such, and should only be viewed as historical data.

**Industry, Ranking and Market Data**

Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the markets in which we operate, including our general expectations about our industry, market position, market opportunity and market sizes, is based on data from various sources including internal data and estimates as well as third-party sources widely available to the public, such as independent industry publications, government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third-party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management's understanding of industry conditions, and such information has not been verified by any independent sources. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we generally believe the market, industry and other information included in this Quarterly Report on Form 10-Q to be the most recently available and to be reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.

Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word "fiscal" refers to the fiscal year ended June 30 of that year. For example, references to "fiscal 2023" refer to the fiscal year ending June 30, 2023. Any reference to a year not preceded by "fiscal" refers to a calendar year.

**OVERVIEW**

We are one of the world's largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, and skin and body care. Through targeted strategic transactions, we have strengthened and diversified our presence across the countries, categories and channels in which we compete, building a strong beauty platform. As we transform the Company, we continue to make progress on our strategic priorities, including stabilizing and growing our Consumer Beauty brands through leading innovation and improved execution, accelerating our Prestige fragrance business and ongoing expansion into Prestige cosmetics, building a comprehensive skincare portfolio leveraging existing brands, enhancing our e-commerce and Direct-to-Consumer ("DTC") capabilities, expanding our presence in China through Prestige products and select Consumer Beauty brands, and establishing Coty as an industry leader in sustainability.

We remain attentive to economic and geopolitical conditions that may materially impact our business. We continue to explore and implement risk mitigation strategies in the face of these unfolding conditions and remain agile in adapting to changing circumstances. Such conditions have or may have global implications which may impact the future performance of our business in unpredictable ways.

Our operations outside of the United States account for a significant portion of our revenues and expenses. As a result, a substantial portion of our total revenue and expenses are denominated in currencies other than the U.S. dollar. Exchange rates between certain of these currencies and the U.S. dollar have fluctuated significantly and may continue to do so in the future. Fluctuations in foreign exchange rates may have a significant impact our operating results. During the first half of fiscal 2023, fluctuations in the U.S. dollar relative to certain other foreign currencies – such as the euro and British pound – reduced our

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

reported revenue and expenses, principally related to cost of sales, controllable fixed costs, and advertising and consumer promotional costs. Refer to Part I, Item 1A under the heading "Risk Factors" in our Annual Report on Form 10-K for fiscal 2022, for a discussion of these factors and other risks.

We expect that our net revenue for fiscal year 2023 will grow in the mid-to high single digits versus the prior year, excluding the impact of foreign exchange and the impact of the Russia exit.

*Global Supply Chain Challenges*

We continue to experience global supply chain challenges resulting from industry-wide component shortages and transportation delays. These challenges have negatively impacted order fill rates across our product categories, particularly prestige fragrances where there has been demand growth, especially in North America and certain European countries.

We continue to take steps to improve order fill rates and mitigate the impact of these constraints, including working closely with our suppliers to ensure the availability of components such as glass and metal, and building our inventory levels to meet demand. However, we expect these challenges to continue into the remainder of the fiscal year 2023.

*Inflation*

Inflationary trends in certain markets and global supply chain challenges may negatively affect our sales and operating performance. We continued to experience the impact of inflation on material, logistical and other costs during the first half of fiscal 2023. The combination of our strategy to premiumize the portfolio, cost savings programs, and recent pricing actions are enabling us to offset inflationary pressure on costs. We currently anticipate the impact of inflation to continue into the second half fiscal of 2023. We will continue to implement mitigation strategies and price increases to offset these trends; however, such measures may not fully offset the impact to our operating performance. After the resumption of more typical business conditions, the economics of developing, producing, launching, supporting and discontinuing products will continue to impact the timing of our sales and operating performance each period.

*Russia-Ukraine War*

We continue to wind down the operations of our Russian subsidiary. In connection with our wind down, we liquidated a portion of our remaining inventory in Russia, in accordance with applicable sanctions, during the first half of fiscal 2023. We anticipate incurring up to $8.0 of additional costs through completion of the wind down, and future net cash costs of $30.0 to $35.0, which will be funded by our Russian subsidiary. Additionally, management anticipates derecognizing the cumulative translation adjustment balance pertaining to the Russian subsidiary. The amount of future costs, including cash costs, will be subject to various factors, such as additional government regulation and the resolution of legal contingencies. We have substantially completed our commercial activities in Russia. However, we anticipate that the process related to the liquidation of the Russian legal entity will take an extended period of time.

*Non-GAAP Financial Measures*

To supplement the financial measures prepared in accordance with GAAP, we use non-GAAP financial measures for continuing operations and Coty Inc. including Adjusted operating income (loss), Adjusted EBITDA, Adjusted net income (loss), and Adjusted net income (loss) attributable to Coty Inc. to common stockholders (collectively, the "Adjusted Performance Measures"). The reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in tables below. These non-GAAP financial measures should not be considered in isolation from, or as a substitute for or superior to, financial measures reported in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of the business as determined in accordance with GAAP. Other companies, including companies in the beauty industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Despite the limitations of these non-GAAP financial measures, our management uses the Adjusted Performance Measures as key metrics in the evaluation of our performance and annual budgets and to benchmark performance of our business against our competitors. The following are examples of how these Adjusted Performance Measures are utilized by our management:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• strategic plans and annual budgets are prepared using the Adjusted Performance Measures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• senior management receives a monthly analysis comparing budget to actual operating results that is prepared using the Adjusted Performance Measures; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• senior management's annual compensation is calculated, in part, by using some of the Adjusted Performance Measures.

In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these Adjusted Performance Measures.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

Our management believes that Adjusted Performance Measures are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP financial measures address questions we routinely receive from analysts and investors and, in order to ensure that all investors have access to the same data, our management has determined that it is appropriate to make this data available to all investors. The Adjusted Performance Measures exclude the impact of certain items (as further described below) and provide supplemental information regarding our operating performance. By disclosing these non-GAAP financial measures, our management intends to provide investors with a supplemental comparison of our operating results and trends for the periods presented. Our management believes these measures are also useful to investors as such measures allow investors to evaluate our performance using the same metrics that our management uses to evaluate past performance and prospects for future performance. We provide disclosure of the effects of these non-GAAP financial measures by presenting the corresponding measure prepared in conformity with GAAP in our financial statements, and by providing a reconciliation to the corresponding GAAP measure so that investors may understand the adjustments made in arriving at the non-GAAP financial measures and use the information to perform their own analyses.

Adjusted operating income/Adjusted EBITDA from continuing operations excludes restructuring costs and business structure realignment programs, amortization, acquisition- and divestiture-related costs and acquisition accounting impacts, stock-based compensation, and asset impairment charges and other adjustments as described below. For adjusted EBITDA, in addition to the preceding, we exclude adjusted depreciation as defined below. We do not consider these items to be reflective of our core operating performance due to the variability of such items from period-to-period in terms of size, nature and significance. They are primarily incurred to realign our operating structure and integrate new acquisitions, and implement divestitures of components of our business, and fluctuate based on specific facts and circumstances. Additionally, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share are adjusted for certain interest and other (income) expense items and preferred stock deemed dividends, as described below, and the related tax effects of each of the items used to derive Adjusted net income as such charges are not used by our management in assessing our operating performance period-to-period.

Adjusted Performance Measures reflect adjustments based on the following items:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Costs related to acquisition and divestiture activities: We have excluded acquisition- and divestiture-related costs and the accounting impacts such as those related to transaction costs and costs associated with the revaluation of acquired inventory in connection with business combinations because these costs are unique to each transaction. Additionally, for divestitures, we exclude write-offs of assets that are no longer recoverable and contract related costs due to the divestiture. The nature and amount of such costs vary significantly based on the size and timing of the acquisitions and divestitures, and the maturities of the businesses being acquired or divested. Also, the size, complexity and/or volume of past transactions, which often drives the magnitude of such expenses, may not be indicative of the size, complexity and/or volume of any future acquisitions or divestitures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Restructuring and other business realignment costs: We have excluded costs associated with restructuring and business structure realignment programs to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Asset impairment charges: We have excluded the impact of asset impairments as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amortization expense: We have excluded the impact of amortization of finite-lived intangible assets, as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance. Although we exclude amortization of intangible assets from our non-GAAP expenses, our management believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Costs related to market exit: We have excluded the impact of direct incremental costs related to our decision to wind down our business operations in Russia. We believe that these direct and incremental costs are inconsistent and infrequent in nature. Consequently, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gains on sale of real estate: We have excluded the impact of Gains on sale of real estate as such amounts are inconsistent in amount and frequency and are significantly impacted by the size of the sale. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Stock-based compensation: Although stock-based compensation is a key incentive offered to our employees, we have excluded the effect of these expenses from the calculation of adjusted operating income and adjusted EBITDA. This is due to their primarily non-cash nature; in addition, the amount and timing of these expenses may be highly variable and unpredictable, which may negatively affect comparability between periods.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Depreciation and Adjusted depreciation: Our adjusted operating income excludes the impact of accelerated depreciation for certain restructuring projects that affect the expected useful lives of Property, Plant and Equipment, as such charges vary significantly based on the size and timing of the programs. Further, we have excluded adjusted depreciation, which represents depreciation expense net of accelerated depreciation charges, from our adjusted EBITDA. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Other (income) expense: We have excluded the impact of pension curtailment (gains) and losses and pension settlements as such events are triggered by our restructuring and other business realignment activities and the amount of such charges vary significantly based on the size and timing of the programs. Further, we have excluded the change in fair value of the investment in Wella, as our management believes these unrealized (gains) and losses do not reflect our underlying ongoing business, and the adjustment of such impact helps investors and others compare and analyze performance from period to period. We have excluded the gain on the exchange of Series B Preferred Stock. Such transactions do not reflect our operating results and we have excluded the impact as our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Noncontrolling interest: This adjustment represents the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interests based on the relevant noncontrolling interest percentage.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Tax: This adjustment represents the impact of the tax effect of the pretax items excluded from Adjusted net income. The tax impact of the non-GAAP adjustments is based on the tax rates related to the jurisdiction in which the adjusted items are received or incurred. Additionally, adjustments are made for the tax impact of any intra-entity transfer of assets and liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>•</sup> Deemed Preferred Stock Dividends: We have excluded preferred stock deemed dividends related to the First Exchange and the Second Exchange (as disclosed and defined in Note 13—Equity Investments in our Annual Report on Form 10-K for fiscal 2022) from our calculation of adjusted net income attributable to Coty Inc. These deemed dividends are nonmonetary in nature, the transactions were entered into to simplify our capital structure and do not reflect our underlying ongoing business. Management believes that this adjustment helps investors and others compare and analyze our performance from period to period.

While acquiring brands and licenses comprises a part of our overall growth strategy, along with targeting organic growth opportunities, we have excluded acquisition-related costs and acquisition accounting impacts in connection with business combinations because these costs are unique to each transaction and the amount and frequency are not consistent and are significantly impacted by the timing and size of our acquisitions. Our management assesses the success of an acquisition as a component of performance using a variety of indicators depending on the size and nature of the acquisition, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the scale of the combined company by evaluating consolidated and segment financial metrics;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the expansion of product offerings by evaluating segment, brand, and geographic performance and the respective strength of the brands;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the evaluation of share expansion in categories and geographies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the earnings per share accretion and substantial incremental free cash flow generation providing financial flexibility for us; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the comparison of actual and projected results, including achievement of projected synergies, post integration; provided that timing for any such comparison will depend on the size and complexity of the acquisition.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

*Constant Currency*

We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented in "constant currency", excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using prior year foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.

*Basis of Presentation of Acquisitions, Divestitures and Terminations*

During the period when we complete an acquisition, divestiture or early license termination, the financial results of the current year period are not comparable to the financial results presented in the prior year period. When explaining such changes from period to period and to maintain a consistent basis between periods, we exclude the financial contribution of: (i) the acquired brands or businesses in the current year period until we have twelve months of comparable financial results and (ii) the divested brands or businesses or early terminated brands, to maintain comparable financial results with the current fiscal year period. There are no acquisitions, divestitures or early license terminations in the comparable periods that would impact the comparability of financial results between periods presented in the Management's Discussion and Analysis of Financial Condition and Results of Operations.

**THREE MONTHS ENDED DECEMBER 31, 2022 AS COMPARED TO THREE MONTHS ENDED DECEMBER 31, 2021** 

NET REVENUES

In the three months ended December 31, 2022, net revenues decreased 3%, or $54.6, to $1,523.6 from $1,578.2 in the three months ended December 31, 2021, reflecting a negative foreign currency exchange translation impact of 7%, and a decrease in unit volume of 5%, partially offset by a positive price and mix impact of 9%. The overall decrease in net revenues reflects a decline in the Prestige fragrance category due to the negative foreign currency exchange translation impact, market exit from Russia, and component constraints. Additionally, there was a decline in net revenues in the makeup category, which was negatively impacted by COVID-19 related declines in Asia Pacific travel and lockdowns in China. Despite the overall decline in net revenues for the Prestige segment, the segment benefited from the continued success of fragrance brands, such as *Marc Jacobs* and *Burberry*. Additionally, there was growth in travel retail sales for the Americas and Europe due to increased leisure travel in the period. The Consumer Beauty segment remained relatively flat, benefiting from the continued success of the body care and skincare brands. Additionally, foreign exchange headwinds negatively impacted net revenues significantly, primarily affecting the euro and British pound.

The overall change in net revenues was impacted by our ongoing market exit from Russia, resulting in an approximate 2% negative net impact on our net revenues in the current quarter, including an approximate 3% negative net impact on our Prestige business net revenues.

***Net Revenues by Segment***

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** |<br>**Change %** |
| **NET REVENUES** |  |  |  |
| &nbsp;&nbsp;&nbsp;Prestige | $957.7 | $1008.0 | (5)% |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 565.9 | 570.2 | (1)% |
| &nbsp;&nbsp;&nbsp;**Total** | $**1523.6** | $**1578.2** | **(3)%** |

---

*Prestige*

In the three months ended December 31, 2022, net revenues from the Prestige segment decreased 5%, or $50.3 to $957.7 compared to $1,008.0 in the three months ended December 31, 2021, reflecting a negative foreign currency exchange translation impact of 8% and a decrease in unit volume of 6%, partially offset by a positive price and mix impact of 9%. This decrease in net revenues primarily reflects:

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)lower net revenues for the *Lacoste* brand in the current quarter, which was primarily due to our market exit from Russia and supply chain constraints;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)lower net revenues in the Prestige makeup category impacted by a decline in *Gucci* travel retail sales in the Asia Pacific region as a result of the lockdowns in China; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)lower net revenues related to *Hugo Boss* and *Gucci* primarily due to the negative foreign currency exchange translation impact, mainly attributable to the euro, despite the positive impact from pricing and from successful innovation in the *Boss Bottled* and *Gucci Flora* fragrances.

These decreases in net revenues were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the continued success and growth of prestige fragrances, specifically *Marc Jacobs Daisy, Burberry Hero* and *Burberry Her;* and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)an increase in net revenues due to positive pricing impact as a result of global price increases and an overall premiumization strategy.

*Consumer Beauty*

In the three months ended December 31, 2022, net revenues from the Consumer Beauty segment decreased 1%, or $4.3, to $565.9 from $570.2 in the three months ended December 31, 2021, reflecting a negative foreign currency exchange translation impact of 7%, a decrease in unit volume of 5%, partially offset by positive price and mix impact of 11%. The decrease in net revenues primarily reflects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)a decline in net revenues from fragrance and color cosmetics categories, despite an overall positive impact from pricing, as a result of negative foreign currency exchange translation impacts which had a significant impact on net sales in these categories.

These decreases in net revenues were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)an increase in net revenues from the skin and body care brands in Brazil due to strong category momentum and market share gains, and positive pricing impact and product mix, as well as due to innovation in brands such as *Monange*;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)an increase in net revenues for *CoverGirl* driven by category growth in the U.S. as well as higher sell out resulting in lower returns and markdowns compared to the prior year; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)an increase in net revenues due to price increases across the Consumer Beauty product portfolio.

COST OF SALES

In the three months ended December 31, 2022, cost of sales decreased 6%, or $35.8, to $525.3 from $561.1 in the three months ended December 31, 2021. Cost of sales as a percentage of net revenues decreased to 34.5% in the three months ended December 31, 2022 from 35.6% in the three months ended December 31, 2021, resulting in a gross margin increase of approximately 110 basis points, primarily reflecting:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)approximately 190 basis points related to positive price impact across our product portfolio;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)approximately 60 basis points in decreased excess and obsolescence costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)approximately 60 basis points related to designer license fees due to favorable royalty related activity, as well as the impact of our licensed brand sales comprising a lower portion of overall net sales compared to the comparative period;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)approximately 40 basis points due to lower returns and markdown costs for the Consumer Beauty division as a result of higher sell through compared to the prior year period and lower returns volume for products in the Prestige division primarily in the US market; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)approximately 20 basis points related to a favorable impact on variable costs due to increased manufacturing efficiencies, improvements in productivity as well as procurement and material cost optimization.

These increases were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)approximately 240 basis points related to product mix impact associated with increased contribution from lower margin Consumer Beauty products primarily in Brazil; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)approximately 20 basis points related to increased freight costs.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

Included in the above is the negative impact of inflation on material and freight costs of approximately 130 basis points, which benefited temporarily from the timing of cost increases in certain materials.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the three months ended December 31, 2022, selling, general and administrative expenses increased 5%, or $35.4, to $754.3 from $718.9 in the three months ended December 31, 2021. Selling, general and administrative expenses as a percentage of net revenues increased to 49.5% in the three months ended December 31, 2022 from 45.6% in the three months ended December 31, 2021, or approximately 390 basis points. This increase primarily reflects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)540 basis points due to a gain on sale of real estate that was recorded in the comparative period;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)150 basis points due to unfavorable transactional impact from our exposure to foreign currency exchange fluctuations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)40 basis points due to an increase in stock-based compensation expense as a percentage of net revenues principally due to awards granted in the second quarter.

These increases were partially offset by the following decreases:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)210 basis points due to decrease in advertising and consumer promotional costs as a percentage of net revenue primarily related to a reduction of working media costs in the period due to an adjustment to the level of spend due to the constrained availability of Prestige fragrances due to the component shortages;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)80 basis points due to a decrease in bad debt expense as a percentage of net revenues;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)30 basis points due to a decrease in administrative costs as a percentage of net revenues due to a decrease in compensation related to a reduction in bonus expense; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)20 basis points due to a decrease in logistics costs as a percentage of net revenues.

OPERATING INCOME

In the three months ended December 31, 2022, operating income was $199.3 compared to income of $244.0 in the three months ended December 31, 2021. Operating income as a percentage of net revenues, decreased to 13.1% in the three months ended December 31, 2022 as compared to an operating income as a percentage of net revenues of 15.5% in the three months ended December 31, 2021. The decline in operating margin is primarily driven by a gain on the sale of real estate recognized in the comparative period, partially offset by a decrease in advertising and consumer promotional costs as a percentage of net revenues, and a decrease in cost of goods sold as a percentage of net revenues.

***Operating Income (Loss) by Segment***

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** |<br>**Change %** |
| **Operating income (loss)** |  |  |  |
| &nbsp;&nbsp;&nbsp;Prestige | $164.4 | $141.6 | 16% |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 49.4 | 43.3 | 14% |
| &nbsp;&nbsp;&nbsp;Corporate | (14.5) | 59.1 | <(100%) |
| &nbsp;&nbsp;&nbsp;**Total** | $**199.3** | $**244.0** | **(18)%** |

---

*Prestige* 

In the three months ended December 31, 2022, operating income for Prestige was $164.4 compared to income of $141.6 in the three months ended December 31, 2021. Operating margin increased to 17.2% of net revenues in the three months ended December 31, 2022 as compared to 14.0% in the three months ended December 31, 2021, driven by a decrease in advertising and consumer promotional costs as a percentage of net revenues, a decrease in cost of goods sold as a percentage of net revenues and a decrease in fixed costs, partially offset by unfavorable transactional impact from our exposure to foreign currency exchange fluctuations.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

*Consumer Beauty*

In the three months ended December 31, 2022, operating income for Consumer Beauty was $49.4 compared to income of $43.3 in the three months ended December 31, 2021. Operating margin increased to 8.7% of net revenues in the three months ended December 31, 2022 as compared to 7.6% in the three months ended December 31, 2021, driven by a decrease advertising and consumer promotional costs as a percentage of net revenues and lower fixed costs, partially offset by unfavorable transactional impact from our exposure to foreign currency exchange fluctuations and an increase in cost of goods sold as a percentage of net revenues.

*Corporate*

Corporate primarily includes income and expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the three months ended December 31, 2022, the operating loss for Corporate was $14.5 compared to an income of $59.1 in the three months ended December 31, 2021, as described under "Adjusted Operating Income (Loss) for Continuing Operations" below. The increase in the operating loss for Corporate was primarily driven by a gain on the sale of real estate recognized in the comparative period, higher stock compensation expense, partially offset by a gain recognized related to our market exit from Russia.

***Adjusted Operating Income (Loss) by Segment***

We believe that adjusted operating income (loss) by segment further enhances an investor's understanding of our performance. See "Overview—Non-GAAP Financial Measures." A reconciliation of reported operating income (loss) to adjusted operating income is presented below, by segment:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
|<br>**(in millions)** | **Reported<br>(GAAP)** | **Adjustments** <sup>(a)</sup> | **Adjusted <br>(Non-GAAP)** |
| **Operating income (loss)** | | | |
| &nbsp;&nbsp;&nbsp;Prestige | $164.4 | $37.3 | $201.7 |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 49.4 | 10.3 | 59.7 |
| &nbsp;&nbsp;&nbsp;Corporate | (14.5) | 14.5 |  |
| &nbsp;&nbsp;&nbsp;**Total** | $**199.3** | $**62.1** | $**261.4** |
|  | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
| **(in millions)** | **Reported<br>(GAAP)** | **Adjustments** <sup>(a)</sup> | **Adjusted <br>(Non-GAAP)** |
| **Operating income (loss)** |  |  |  |
| &nbsp;&nbsp;&nbsp;Prestige | $141.6 | $40.4 | $182.0 |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 43.3 | 11.0 | 54.3 |
| &nbsp;&nbsp;&nbsp;Corporate | 59.1 | (59.1) |  |
| &nbsp;&nbsp;&nbsp;**Total** | $**244.0** | $**(7.7)** | $**236.3** |

---

<sup>(a)</sup>See a reconciliation of reported operating income to adjusted operating income and a description of the adjustments under "Adjusted Operating Income for Continuing Operations" below. All adjustments are reflected in Corporate, except for amortization and asset impairment charges on goodwill, indefinite-lived intangible assets, and finite-lived intangible assets, which are reflected in the Prestige and Consumer Beauty segments.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

***Adjusted Operating Income and Adjusted EBITDA for Continuing Operations***

We believe that adjusted operating income further enhances an investor's understanding of our performance. See "Overview—Non-GAAP Financial Measures." Reconciliation of reported operating income to adjusted operating income is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** |<br>**Change %** |
| **Reported operating income** | $**199.3** | $**244.0** | **(18)%** |
| *% of net revenues* | *13.1 %* | *15.5 %* |  |
| &nbsp;&nbsp;&nbsp;Amortization expense | 47.6 | 51.4 | (7)% |
| &nbsp;&nbsp;&nbsp;Restructuring and other business realignment costs | (2.9) | (1.8) | (61)% |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 34.2 | 27.5 | 24% |
| &nbsp;&nbsp;&nbsp;Costs related to acquisition and divestiture activities |  | 6.9 | (100)% |
| &nbsp;&nbsp;&nbsp;Gain on sale of real estate |  | (91.7) | 100% |
| &nbsp;&nbsp;&nbsp;Gain related to market exit | (16.8) |  | N/A |
| Total adjustments to reported operating income | $62.1 | $(7.7) | >100% |
| **Adjusted operating income** | $**261.4** | $**236.3** | **11%** |
| *% of net revenues* | *17.2 %* | *15.0 %* |  |
| &nbsp;&nbsp;&nbsp;Adjusted depreciation | 56.2 | 75.6 | (26)% |
| **Adjusted EBITDA** | $**317.6** | $**311.9** | 2% |
| *% of net revenues* | *20.8 %* | *19.8 %* |  |

---

In the three months ended December 31, 2022, adjusted operating income increased $25.1 to $261.4 from $236.3 in the three months ended December 31, 2021. Adjusted operating margin increased to 17.2% of net revenues in the three months ended December 31, 2022 from 15.0% in the three months ended December 31, 2021. In the three months ended December 31, 2022, adjusted EBITDA increased $5.7 to $317.6 from $311.9 in the three months ended December 31, 2021. Adjusted EBITDA margin increased to 20.8% of net revenues in the three months ended December 31, 2022 from 19.8% in the three months ended December 31, 2021, primarily driven by lower advertising and consumer promotional costs as a percentage of revenues, lower cost of sales as a percentage of net revenues, and lower fixed costs, partially offset by an increase in stock compensation expense.

*Amortization Expense* 

In the three months ended December 31, 2022, amortization expense decreased to $47.6 from $51.4 in the three months ended December 31, 2021. In the three months ended December 31, 2022, amortization expense of $37.3 and $10.3 was reported in the Prestige and Consumer Beauty segments, respectively. In the three months ended December 31, 2021, amortization expense of $40.4 and $11.0 was reported in the Prestige and Consumer Beauty segments, respectively. The decrease was primarily driven by certain license agreements and product formulations, which were fully amortized in the prior year.

*Restructuring and Other Business Realignment Costs*

We continue to analyze our cost structure, including opportunities to simplify and optimize operations. In connection with the four-year Turnaround plan announced on July 1, 2019 to drive substantial improvement and optimization in our business, we have and expect to continue to incur restructuring and other business realignment costs. On May 11, 2020, we announced an expansion of the Turnaround Plan to further reduce fixed costs, the Transformation Plan. We incurred $507.6 of cash costs life-to-date as of December 31, 2022, which have been recorded in Corporate.

In the three months ended December 31, 2022, we incurred a credit in restructuring and other business structure realignment costs of $(2.9), as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred a credit in restructuring costs of $(2.9) primarily related to the Transformation Plan changes in estimates, included in the Condensed Consolidated Statements of Operations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred no business structure realignment costs.

In the three months ended December 31, 2021, we incurred a credit in restructuring and other business structure realignment costs of $(1.8) as follows:

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred a credit in restructuring costs of $(4.1) primarily related to the Transformation Plan, included in the Condensed Consolidated Statements of Operations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred business structure realignment costs of $2.3 primarily related to the Transformation Plan and certain other programs. This amount includes $(0.3) reported in Selling, general and administrative expenses, and $2.6 reported in Cost of sales in the Condensed Consolidated Statement of Operations.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

*Stock-Based Compensation*

In the three months ended December 31, 2022, stock-based compensation was $34.2 as compared with $27.5 in the three months ended December 31, 2021. The increase in stock-based compensation is primarily related to awards granted in the second quarter.

In the three months ended December 31, 2022 and 2021, all costs related to stock-based compensation were reported in Corporate.

*Acquisition and Divestiture Activities*

In the three months ended December 31, 2022 we incurred no costs related to acquisition and divestiture activities.

In the three months ended December 31, 2021, we incurred $6.9 of costs related to acquisition and divestiture activities. These costs were primarily associated with the Wella Transaction.

In all reported periods, all costs related to acquisition and divestiture activities were reported in Corporate.

*Gain on Sale of Real Estate*

In the three months ended December 31, 2022, we did not recognize any gain related to sale of real estate.

In the three months ended December 31, 2021, we recognized gain of $91.7 related to sale of real estate.

*Gain Related to Market Exit*

In the three months ended December 31, 2022, we recognized a gain of $16.8 related to our market exit from Russia which are included in Selling, general and administrative expenses and Cost of sales in the Consolidated Statements of Operations.

In the three months ended December 31, 2021, we did not incur any market exit costs.

*Adjusted Depreciation Expense*

In the three months ended December 31, 2022, adjusted depreciation expense of $26.8 and $29.4 was reported in the Prestige and Consumer Beauty segments, respectively. In the three months ended December 31, 2021, adjusted depreciation expense of $37.0 and $38.6 was reported in the Prestige and Consumer Beauty segments, respectively.

INTEREST EXPENSE, NET

In the three months ended December 31, 2022, net interest expense was $61.0 as compared with $60.9 in the three months ended December 31, 2021. This relatively flat change in interest expense reflects a higher average interest on lower debt balances in the current period.

OTHER INCOME

In the three months ended December 31, 2022, other income was $141.9 as compared with other income of $126.2 in the three months ended December 31, 2021. This increase in income is principally due to an increase in income due to a fair value adjustment for our forward repurchase contracts, partially offset by a less favorable fair value adjustment related to our investment in the Wella Company compared to the prior period.

INCOME TAXES

The effective income tax rate for the three months ended December 31, 2022 and 2021 was 13.8% and 16.0%, respectively. The change in the effective tax rate for the three months ended December 31, 2022, as compared with the three months ended December 31, 2021, is primarily due to foreign exchange loss recognized on the current year repatriation of funds that were previously taxed as part of the Tax Cuts and Jobs Act of 2017 and the larger nondeductible executive stock compensation in the period.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to our unrecognized tax benefits and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

**Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31, 2022** | **Three Months Ended<br>December 31, 2022** | **Three Months Ended<br>December 31, 2022** | **Three Months Ended<br>December 31, 2021** | **Three Months Ended<br>December 31, 2021** | **Three Months Ended<br>December 31, 2021** |
|<br>**(in millions)** | **Income Before Income Taxes** | **Provision for Income Taxes** | **Effective Tax Rate** | **Income Before Income Taxes** | **Provision for Income Taxes** | **Effective Tax Rate** |
| **Reported income before income taxes** | $**280.2** | $**38.8** | **13.8%** | $**309.3** | $**49.4** | **16.0%** |
| Adjustments to reported operating income <sup>(a)</sup> | 62.1 |  |  | (7.7) |  |  |
| Change in fair value of investment in Wella Business <sup>(c)</sup> | (75.0) |  |  | (128.3) |  |  |
| Other adjustments <sup>(d)</sup> | 0.2 |  |  | (3.0) |  |  |
| Total Adjustments <sup>(b)</sup> | (12.7) | 28.7 |  | (139.0) | (33.1) |  |
| **Adjusted income before income taxes** | $**267.5** | $**67.5** | **25.2%** | $**170.3** | $**16.3** | **9.6%** |

---

<sup>(a)</sup>See a description of adjustments under "Adjusted Operating Income for Continuing Operations."

<sup>(b)</sup>The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.

<sup>(c)</sup>The amount represents the realized and unrealized (gain) loss recognized for the change in fair value of the investment in Wella.

<sup>(d)</sup>For the three months ended December 31, 2022, this primarily represents adjustments for equity loss from KKW. For the three months ended December 31, 2021, this primarily represents a net gain on the exchange of Series B Preferred Stock closed on October 20, 2021.

The adjusted effective tax rate was 25.2% for the three months ended December 31, 2022 compared to 9.6% for the three months ended December 31, 2021. The differences were primarily due to a benefit of $18.8 in the prior period recognized on the revaluation of the Company's deferred tax assets due to a tax rate increase enacted in the Netherlands.

NET INCOME ATTRIBUTABLE TO COTY INC.

Net income attributable to Coty Inc. was $238.3 in the three months ended December 31, 2022 as compared to net income of $261.4 in the three months ended December 31, 2021. The decrease in the income is primarily driven by the lower unrealized gain in the Wella investment and lower operating income, partially offset by a decrease in tax provision in the current period.

We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See "Overview—Non-GAAP Financial Measures."

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** |<br>**Change %** |
| **Net income from Coty Inc. net of noncontrolling interests** | $**238.3** | $**261.4** | **(9)%** |
| Convertible Series B Preferred Stock dividends <sup>(a)</sup> | (3.3) | (68.7) | 95% |
| **Reported net income attributable to Coty Inc.** | $**235.0** | $**192.7** | **22%** |
| *% of net revenues* | *15.4 %* | *12.2 %* |  |
| &nbsp;&nbsp;Adjustments to reported operating income <sup>(b)</sup> | 62.1 | (7.7) | >100% |
| &nbsp;&nbsp;Adjustments to Loss on Sale of Business <sup>(c)</sup> |  | (4.8) | 100% |
| &nbsp;&nbsp;Change in fair value of investment in Wella Company <sup>(d)</sup> | (75.0) | (128.3) | 42% |
| &nbsp;&nbsp;Adjustment to other expense <sup>(e)</sup> | 0.2 | (3.0) | >100% |
| &nbsp;&nbsp;Adjustments to noncontrolling interests <sup>(f)</sup> | (1.7) | (1.7) | —% |
| Change in tax provision due to adjustments to reported net income attributable to Coty Inc. | (28.7) | 34.1 | <(100%) |
| Adjustment for deemed Series B Preferred Stock dividends related to the First and Second Exchanges <sup>(a) (g)</sup> |  | 66.4 | (100)% |
| **Adjusted net income attributable to Coty Inc.** | $**191.9** | $**147.7** | **30%** |
| *% of net revenues* | *12.6 %* | *9.4 %* |  |
| **Per Share Data** |  |  |  |
| Adjusted weighted-average common shares |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 850.8 | 829.1 |  |
| &nbsp;&nbsp;Diluted <sup>(a)</sup> | 886.8 | 892.3 |  |
| Adjusted net income attributable to Coty Inc. per common share |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $0.23 | $0.18 |  |
| &nbsp;&nbsp;Diluted <sup>(a)</sup> | $0.22 | $0.17 |  |

---

(a)Adjusted Diluted EPS is adjusted by the effect of dilutive securities. For the three months ended December 31, 2022, shares for the Forward Repurchase Contracts were excluded from the computation of adjusted diluted EPS as Coty is in the position to receive shares from the counterparties and as such their inclusion would be anti-dilutive. Accordingly, we did not reverse the impact of the fair market value (gain) for contracts with the option to settle in shares or cash of ($44.3). For the three months ended December 31, 2022 and 2021, as the Convertible Series B Preferred Stock was dilutive, an adjustment to reverse the impact of the preferred stock dividends of $3.3 and $2.3, respectively, was required.

<sup>(b)</sup>See a description of adjustments under "Adjusted Operating Income for Continuing Operations."

<sup>(c)</sup>For the three months ended December 31, 2021, this amount reflects certain purchase price working capital adjustments related to the sale of the Wella business.

<sup>(d)</sup>For the three months ended December 31, 2022 and 2021, the amount represents the unrealized (gain) loss recognized for the change in fair value of the investment in Wella.

<sup>(e)</sup>For the three months ended December 31, 2022, this primarily represents the loss from equity investment in KKW. For the three months ended December 31, 2021, this primarily represents a net gain on the exchange of Series B Preferred Stock closed on October 20, 2021.

<sup>(f)</sup>The amounts represent the after-tax impact of the non-GAAP adjustments included in net income attributable to noncontrolling interests based on the relevant noncontrolling interest percentage in the Condensed Consolidated Statements of Operations.

<sup>(g)</sup>For the three months ended December 31, 2021, this adjustment represents the deemed dividend from the Exchange Agreement on September 30, 2021. The deemed dividend is the result of carrying the Convertible Series B Preferred Stock at fair value.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**SIX MONTHS ENDED DECEMBER 31, 2022 AS COMPARED TO SIX MONTHS ENDED DECEMBER 31, 2021** 

NET REVENUES

In the six months ended December 31, 2022, net revenues decreased 1%, or $36.3, to $2,913.6 from $2,949.9 in the six months ended December 31, 2021, reflecting a negative foreign currency exchange translation impact of 7%, and a decrease in unit volume of 2%, partially offset by a positive price and mix impact of 8%. The overall decrease in net revenues reflects a decline in Prestige makeup, which was negatively impacted by the lockdowns in China, a decline in the fragrances, due to lack of innovation in key fragrance brands, such as *Tiffany*, the exit from Russia, and fragrance component constraints. Despite the overall decline in net revenues for the Prestige segment, the segment benefited from the continued success of fragrance brands, such as *Gucci, Burberry, Chloe* and *Marc Jacobs*. Additionally, there was growth in travel retail sales due to increased leisure travel in the period. The Consumer Beauty segment experienced positive performance across the body care and skincare brands primarily in Brazil. The overall increase in net revenues reflects the successful implementation of global price increases across all product categories, our product premiumization strategy, and positive overall market trends. Foreign exchange headwinds, however, negatively impacted net revenues significantly, primarily affecting the euro and British pound transactions.

The overall change in net revenues was impacted by our ongoing exit from Russia, resulting in an approximate 2% negative net impact on our net revenues for the six months ended December 31, 2022, including an approximate 2% negative net impact on our Prestige business net revenues.

***Net Revenues by Segment***

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** |<br>**Change %** |
| **NET REVENUES** |  |  |  |
| &nbsp;&nbsp;&nbsp;Prestige | $1821.2 | $1878.7 | (3)% |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 1092.4 | 1071.2 | 2% |
| &nbsp;&nbsp;&nbsp;**Total** | $**2913.6** | $**2949.9** | **(1)%** |

---

*Prestige*

In the six months ended December 31, 2022, net revenues from the Prestige segment decreased 3%, or $57.5, to $1,821.2 from $1,878.7 in the six months ended December 31, 2021, reflecting a negative foreign currency exchange translation impact of 8%, and a decrease in unit volume of 4%, partially offset by a positive price and mix impact of 9%. The decrease in net revenues primarily reflects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.lower net revenues for the *Lacoste* brand in the year, which was primarily due to our market exit from Russia and supply chain constraints;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.lower net revenues in the prestige makeup category impacted by a decline in *Gucci* travel retail sales in the Asia Pacific region as a result of the lockdowns in China;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii.lower net revenues related to *Tiffany* due to less innovation in the current fiscal period, the impact of the lockdowns in China and our market exit from Russia; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv.lower net revenues related to *Hugo Boss* due to the negative foreign currency exchange translation impact, mainly impacting euro denominated sales, despite the positive impact due to pricing and innovation in the *Boss Bottled* fragrance.

These decreases in net revenue were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)higher net revenues due to the continued success of Prestige fragrances, such as *Gucci Flora, Burberry Hero and Her*, *Chloe Atelier des Fleurs* and *Marc Jacobs Daisy.*

*Consumer Beauty*

In the six months ended December 31, 2022, net revenues from the Consumer Beauty segment increased 2%, or $21.2, to $1,092.4 from $1,071.2 in the six months ended December 31, 2021, reflecting a positive price and mix impact of 10%, partially offset by a negative foreign currency exchange translation impact of 7%, and a decrease in unit volume of 1%. The increase in net revenues primarily reflects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)an increase in net revenues from the skin and body care brands in Brazil, which had an increase in net revenue due to strong category momentum and market share gains, and positive pricing impact and product mix, as well as due to innovation in brands such as *Monange*;

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)an increase in net revenues for *CoverGirl* driven by category growth in the U.S. as well as higher sell out resulting in lower returns and markdowns compared to the prior year; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)an increase in net revenues due to price increases across the Consumer Beauty product portfolio.

These increases in net revenue were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the continued decline in net revenues for *Sally Hansen* products, resulting from the continued decline for demand for at-home nail care compared to the prior year where COVID-19 restrictions had resulted in fewer nail salon visits and positively impacted the nail category and the brand's net revenue in the prior year; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)a decline in net revenues from fragrance and color cosmetics categories, despite an overall positive impact from pricing, as a result of negative foreign currency exchange translation impacts which had a significant impact on net revenues in these categories.

COST OF SALES

In the six months ended December 31, 2022, cost of sales decreased 4%, or $39.3, to $1,026.6 from $1,065.9 in the six months ended December 31, 2021. Cost of sales as a percentage of net revenues decreased to 35.2% in the six months ended December 31, 2022 from 36.1% in the six months ended December 31, 2021 resulting in a gross margin increase of approximately 90 basis points primarily reflecting:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)approximately 140 basis points related to positive price impact across our product portfolio;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)approximately 50 basis points due to lower returns and markdown costs for the Consumer Beauty division as a result of higher sell through compared to the prior year period and lower returns volume for products in the Prestige division primarily in the US and Latin American markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)approximately 40 basis points related to designer license fees due to favorable royalty related activity, as well as the impact of our licensed brand sales comprising a lower portion of overall net sales compared to the comparative period;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)approximately 30 basis points related to a favorable impact on variable costs due to increased manufacturing efficiencies, improvements in productivity as well as procurement and material cost optimization; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)approximately 10 basis points related to lower excess and obsolescence costs.

These decreases were partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)approximately 150 basis points related to product mix impact due to a higher portion of consolidated sales being from the Consumer Beauty division; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)approximately 30 basis points related to higher freight costs.

Included in the above is the negative impact of inflation on material and freight costs of approximately 160 basis points.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the six months ended December 31, 2022, selling, general and administrative expenses decreased 5%, or $70.2, to $1,425.0 from $1,495.2 in the six months ended December 31, 2021. Selling, general and administrative expenses as a percentage of net revenues decreased to 48.9% in the six months ended December 31, 2022 from 50.7% in the six months ended December 31, 2021, or approximately 180 basis points. This decrease was primarily due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)240 basis points due to a decrease in stock-based compensation cost primarily related to a reduction in expense recognized in connection with a prior year's grant made to the CEO;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)180 basis points due to a decrease in advertising and consumer promotional costs as a percentage of net revenue primarily related to a reduction of non-working and working media in the first half of the year due to an adjustment to the level of spend due to the constrained availability of Prestige fragrances due to the component shortages;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)60 basis points due to a decrease in bad debt expense as a percentage of net revenues;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)20 basis points due to a decrease in administrative costs as a percentage of net revenues due to a decrease in compensation related to a reduction in employee headcount; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)20 basis points due to a decrease in logistics costs as a percentage of net revenues.

These decreases were partially offset by the following increases:

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)270 basis points due to a gain on sale of real estate was recorded in the comparative period, partially offset by an accrual reversal associated with the resolution of a contingency in the current period; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)70 basis points due to unfavorable transactional impact from our exposure to foreign currency exchange fluctuations.

OPERATING INCOME

In the six months ended December 31, 2022, operating income was $371.2 compared to income of $261.2 in the six months ended December 31, 2021. Operating margin as a percentage of net revenues, increased to 12.7% in the six months ended December 31, 2022 as compared to an operating income as a percentage of net revenues of 8.9% in the six months ended December 31, 2021. The improved operating margin is largely driven by a decrease in stock compensation expense, a decrease in advertising and consumer promotional costs as a percentage of net revenues, a decrease in cost of goods sold as a percentage of net revenues and a decrease in fixed costs, partially offset by a gain on sale of real estate recognized in the comparative period.

***Operating Income (Loss) by Segment***

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** | **Change %** |
| &nbsp;&nbsp;&nbsp;**Operating income (loss)** |  |  |  |
| &nbsp;&nbsp;&nbsp;Prestige | $335.0 | $273.7 | 22% |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 81.1 | 54.7 | 48% |
| &nbsp;&nbsp;&nbsp;Corporate | (44.9) | (67.2) | 33% |
| &nbsp;&nbsp;&nbsp;**Total** | $**371.2** | $**261.2** | **42%** |

---

*Prestige* 

In the six months ended December 31, 2022, operating income for Prestige was $335.0 compared to income of $273.7 in the six months ended December 31, 2021. Operating margin increased to 18.4% of net revenues in the six months ended December 31, 2022 as compared to 14.6% in the six months ended December 31, 2021, driven primarily by a decrease in cost of goods sold as a percentage of net revenues, a decrease in advertising and consumer promotional costs as a percentage of net revenues, a decrease in fixed costs and a decrease in amortization expense.

*Consumer Beauty*

In the six months ended December 31, 2022, operating income for Consumer Beauty was $81.1 compared to income of $54.7 in the six months ended December 31, 2021. Operating margin increased to 7.4% of net revenues in the six months ended December 31, 2022 as compared to 5.1% in the six months ended December 31, 2021, driven by a decrease in advertising and consumer promotional costs as a percentage of net revenues, a decrease in fixed costs, and a decrease in amortization expense, partially offset by unfavorable foreign exchange translation impact and an increase in cost of goods sold as a percentage of net revenues.

*Corporate*

Corporate primarily includes corporate expenses not directly related to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the six months ended December 31, 2022, the operating loss for Corporate was $44.9 compared to a loss of $67.2 in the six months ended December 31, 2021, as described under "Adjusted Operating Income for Coty Inc." below. The decrease to the operating loss for Corporate was primarily driven by the a gain on the sale of real estate recognized in the comparative period, a decrease in stock compensation expense, and a decrease in costs related to acquisitions and divestiture activities, partially offset by a gain recognized related to our market exit from Russia.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

***Adjusted Operating Income (Loss) by Segment***

We believe that Adjusted Operating income (loss) by segment further enhances an investor's understanding of our performance. See "Overview—Non-GAAP Financial Measures." A reconciliation of reported Operating income (loss) to Adjusted Operating income is presented below, by segment:

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2022** |
|<br>**(in millions)** | **Reported<br>(GAAP)** | **Adjustments** <sup>(a)</sup> | **Adjusted <br>(Non-GAAP)** |
| **Operating income (loss)** | | | |
| &nbsp;&nbsp;&nbsp;Prestige | 335.0 | $74.3 | $409.3 |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 81.1 | 20.6 | 101.7 |
| &nbsp;&nbsp;&nbsp;Corporate | (44.9) | 44.9 |  |
| &nbsp;&nbsp;&nbsp;**Total** | $**371.2** | $**139.8** | $**511.0** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended December 31, 2021** | **Six Months Ended December 31, 2021** | **Six Months Ended December 31, 2021** |
|<br>**(in millions)** | **Reported<br>(GAAP)** | **Adjustments** <sup>(a)</sup> | **Adjusted <br>(Non-GAAP)** |
| **Operating income (loss)** | | | |
| &nbsp;&nbsp;&nbsp;Prestige | 273.7 | $85.4 | $359.1 |
| &nbsp;&nbsp;&nbsp;Consumer Beauty | 54.7 | 23.0 | 77.7 |
| &nbsp;&nbsp;&nbsp;Corporate | (67.2) | 67.2 |  |
| &nbsp;&nbsp;&nbsp;**Total** | $**261.2** | $**175.6** | $**436.8** |

---

<sup>(a)</sup>See a reconciliation of reported operating income to adjusted operating income (loss) and a description of the adjustments under "Adjusted Operating Income (loss) for Coty Inc." below. All adjustments are reflected in Corporate, except for amortization and asset impairment charges on goodwill, regional indefinite-lived intangible assets, and finite-lived intangible assets, which are reflected in the Prestige and Consumer Beauty segments.

***Adjusted Operating Income and Adjusted EBITDA for Continuing Operations***

We believe that adjusted operating income further enhances an investor's understanding of our performance. See "Overview—Non-GAAP Financial Measures." A reconciliation of reported operating income (loss) to adjusted operating income is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** |<br>**Change %** |
| **Reported operating income** | **371.2** | **261.2** | **42%** |
| *% of net revenues* | *12.7 %* | *8.9 %* |  |
| &nbsp;&nbsp;&nbsp;Amortization expense | 94.9 | 108.4 | (12)% |
| &nbsp;&nbsp;&nbsp;Restructuring and other business realignment costs | (3.7) | 13.3 | <(100%) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 65.3 | 135.7 | (52)% |
| &nbsp;&nbsp;&nbsp;Costs related to acquisition and divestiture activities |  | 10.9 | (100)% |
| &nbsp;&nbsp;&nbsp;Gain on sale of real estate | (1.0) | (92.7) | 99% |
| &nbsp;&nbsp;&nbsp;Gain related to market exit | (15.7) |  | N/A |
| Total adjustments to reported operating income | $139.8 | $175.6 | (20)% |
| **Adjusted operating income** | $**511.0** | $**436.8** | **17%** |
| *% of net revenues* | *17.5 %* | *14.8 %* |  |
| &nbsp;&nbsp;&nbsp;Adjusted depreciation | 114.5 | 153.6 | (25)% |
| **Adjusted EBITDA** | $**625.5** | $**590.4** | **6%** |
| *% of net revenues* | *21.5 %* | *20.0 %* |  |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

In the six months ended December 31, 2022, adjusted operating income increased $74.2, to $511.0 from $436.8 in the six months ended December 31, 2021. Adjusted operating margin increased to 17.5% of net revenues in the six months ended December 31, 2022 from 14.8% in the six months ended December 31, 2021. In the six months ended December 31, 2022, adjusted EBITDA increased $35.1 to $625.5 from $590.4 in the six months ended December 31, 2021. Adjusted EBITDA margin increased to 21.5% of net revenues in the six months ended December 31, 2022 from 20.0% in the six months ended December 31, 2021, primarily driven by a decrease in advertising and consumer promotional costs as a percentage of net revenues, a decrease in cost of goods sold as a percentage of net revenues and a decrease in fixed costs.

*Amortization Expense*

In the six months ended December 31, 2022, amortization expense decreased to $94.9 from $108.4 in the six months ended December 31, 2021. In the six months ended December 31, 2022, amortization expense of $74.3 and $20.6 was reported in the Prestige and Consumer Beauty segments, respectively. In the six months ended December 31, 2021, amortization expense of $85.4 and $23.0 was reported in the Prestige and Consumer Beauty segments, respectively. The decrease was primarily driven by certain license agreements and product formulations, which were fully amortized in the prior year.

*Restructuring and Other Business Realignment Costs* 

We continue to analyze our cost structure, including opportunities to simplify and optimize operations. In connection with the four-year Turnaround plan announced on July 1, 2019 to drive substantial improvement and optimization in our business, we have and expect to continue to incur restructuring and other business realignment costs. On May 11, 2020 we announced an expansion of the Turnaround Plan to further reduce fixed costs, the Transformation Plan. We incurred $507.6 of cash costs life-to-date as of December 31, 2022, which have been recorded in Corporate.

In the six months ended December 31, 2022, we incurred a credit in restructuring and other business structure realignment costs of $(3.7), as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred a credit in restructuring costs of $(4.1) primarily related to the Transformation Plan, included in the Condensed Consolidated Statements of Operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred business structure realignment costs of $0.4 primarily related to our Transformation plan and certain other programs. This amount includes $0.9 reported in Cost of sales in the Condensed Consolidated Statement of Operations and a credit of $(0.5) reported in Selling, general and administrative expenses.

In the six months ended December 31, 2021, we incurred restructuring and other business structure realignment costs of $13.3 as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred restructuring costs of $8.3 primarily related to the Transformation Plan, included in the Condensed Consolidated Statements of Operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We incurred business structure realignment costs of $5.0 primarily related to our Transformation Plan. This amount includes $(0.3) reported in Selling, general and administrative expenses, and $5.3 reported in Cost of sales in the Condensed Consolidated Statement of Operations.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

*Stock-based compensation*

In the six months ended December 31, 2022, stock-based compensation was $65.3 as compared with $135.7 in the six months ended December 31, 2021. The decrease in stock-based compensation is primarily related to a reduction in expense recognized in connection with a prior year's grant made to the CEO.

In all reported periods, all costs related to stock-based compensation were reported in Corporate.

*Acquisition and Divestiture Activities* 

In the six months ended December 31, 2022, we incurred no costs related to acquisition and divestiture activities.

In the six months ended December 31, 2021, we incurred $10.9 of cost relating to acquisition and divestiture activities. These costs were primarily associated with the Wella Transaction.

In all reported periods, all costs related to acquisition and divestiture activities were reported in Corporate.

*Gain on Sale of Real Estate*

In the six months ended December 31, 2022 we recognized a gain of $1.0 related to sale of real estate.

In the six months ended December 31, 2021, we recognized a gain of $92.7 related to sale of real estate.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

In all reported periods, all gains related to sale of real estate were reported in Corporate.

*Gain Related to Market Exit*

In the six months ended December 31, 2022, we recognized a gain of $15.7 related to our market exit from Russia which are included in Selling, general and administrative expenses and Cost of sales in the Consolidated Statements of Operations.

In the six months ended December 31, 2021, we did not incur any market exit costs.

*Adjusted depreciation expense*

In the six months ended December 31, 2022, adjusted depreciation expense of $54.3 and $60.2 was reported in the Prestige and Consumer Beauty segments, respectively. In the six months ended December 31, 2021, adjusted depreciation expense of $75.0 and $78.6 was reported in the Prestige and Consumer Beauty segments, respectively.

INTEREST EXPENSE, NET

In the six months ended December 31, 2022, net interest expense was $126.9 as compared with $120.7 in the six months ended December 31, 2021. This increase is primarily due to the impact of a higher average interest rate despite lower debt balances in the current period.

OTHER INCOME

In the six months ended December 31, 2022, other income was $240.1 as compared to other income of $512.3 in the six months ended December 31, 2021. This decrease is primarily due to a less favorable fair value adjustment related to our investment in the Wella Company compared to the prior period, partially offset by the favorable change in the fair value adjustment for our forward repurchase contracts.

INCOME TAXES

The effective income tax rate for the six months ended December 31, 2022 and 2021 was 22.4% and 25.1%, respectively. The change in the effective tax rate for the six months ended December 31, 2022, as compared to the prior period is primarily due to foreign exchange loss recognized on the current year repatriation of funds that were previously taxed as part of the Tax Cuts and Jobs Act of 2017 and the larger nondeductible executive stock compensation in the prior period.

The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of: (i) jurisdictions with different statutory rates, (ii) adjustments to our unrecognized tax benefits and accrued interest; (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

**Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended<br>December 31, 2022** | **Six Months Ended<br>December 31, 2022** | **Six Months Ended<br>December 31, 2022** | **Six Months Ended<br>December 31, 2021** | **Six Months Ended<br>December 31, 2021** | **Six Months Ended<br>December 31, 2021** |
|<br>**(in millions)** | **Income Before Income Taxes** | **Provision for Income Taxes** | **Effective Tax Rate** | **Income Before Income Taxes** | **Provision<br> for Income Taxes** | **Effective<br>Tax Rate** |
| **Reported income before income taxes** | $**484.4** | $**108.5** | **22.4%** | $**652.8** | $**164.0** | **25.1%** |
| Other adjustments to reported operating income <sup>(a)</sup> | 139.8 |  |  | 175.6 |  |  |
| Change in fair value of investment in Wella Business <sup>(c)</sup> | (210.0) |  |  | (518.3) |  |  |
| Other adjustments <sup>(d)</sup> | 0.4 |  |  | (2.8) |  |  |
| **Total Adjustments** <sup>(b)</sup> | (69.8) | 2.5 |  | (345.5) | (108.0) |  |
| **Adjusted income before income taxes** | $**414.6** | $**111.0** | **26.8%** | $**307.3** | $**56.0** | **18.2%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup>See a description of adjustments under "Adjusted Operating Income for Continuing Operations."

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(b)</sup>The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(c)</sup>The amount represents the realized and unrealized (gain) loss recognized for the change in fair value of the investment in Wella.

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(d)</sup>For the six months ended December 31, 2022, this primarily this primarily represents adjustments for equity loss from KKW. For the six months ended December 31, 2021, this primarily represents a net gain on the exchange of Series B Preferred Stock closed on October 20, 2021.

The adjusted effective tax rate was 26.8% for the six months ended December 31, 2022 compared to 18.2% for the six months ended December 31, 2021. The differences were primarily due to a benefit of $18.8 in the prior period recognized on the revaluation of the Company's deferred tax assets due to a tax rate increase enacted in the Netherlands.

NET INCOME ATTRIBUTABLE TO COTY INC.

Net income attributable to Coty Inc. was $366.9 in the six months ended December 31, 2022, as compared to net income of $487.4 in the six months ended December 31, 2021. This decrease in net income was primarily driven by a smaller favorable adjustment related to the realized and unrealized gain in the Wella investment in the current year, partially offset by higher operating income and a decrease in tax provision in the current period.

We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See "Overview—Non-GAAP Financial Measures."

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** | |
|<br>**(in millions)** | **2022** | **2021** |<br>**Change %** |
| **Net income from Coty Inc. net of noncontrolling interests** | **366.9** | **487.4** | **(25)%** |
| Convertible Series B Preferred Stock dividends <sup>(a)</sup> | (6.6) | (191.7) | 97% |
| **Reported net income attributable to Coty Inc.** | **360.3** | **295.7** | **22%** |
| *% of net revenues* | *12.4 %* | *10.0 %* |  |
| &nbsp;&nbsp;Adjustments to reported operating income <sup>(b)</sup> | 139.8 | 175.6 | (20)% |
| &nbsp;&nbsp;Adjustments to Loss on Sale of Business <sup>(c)</sup> |  | (4.8) | 100% |
| &nbsp;&nbsp;Change in fair value of investment in Wella Company <sup>(d)</sup> | (210.0) | (518.3) | 59% |
| &nbsp;&nbsp;Adjustment to other expense <sup>(e)</sup> | 0.4 | (2.8) | >100% |
| &nbsp;&nbsp;Adjustments to noncontrolling interests <sup>(f)</sup> | (3.4) | (3.6) | 6% |
| Change in tax provision due to adjustments to reported net income attributable to Coty Inc. | (2.5) | 109.0 | <(100%) |
| Adjustment for deemed Series B Preferred Stock dividends related to the First and Second Exchanges <sup>(a) (g)</sup> |  | 160.0 | (100)% |
| **Adjusted net income attributable to Coty Inc.** | **284.6** | **210.8** | **35%** |
| *% of net revenues* | *9.8 %* | *7.1 %* |  |
| **Per Share Data** |  |  |  |
| Adjusted weighted-average common shares |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 846.4 | 803.3 |  |
| &nbsp;&nbsp;Diluted <sup>(a)</sup> | 884.5 | 815.1 |  |
| Adjusted net income attributable to Coty Inc. per common share |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $0.34 | $0.26 |  |
| &nbsp;&nbsp;Diluted <sup>(a)</sup> | $0.33 | $0.26 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup>Adjusted Diluted EPS is adjusted by the effect of dilutive securities. For the six months ended December 31, 2022, shares for the Forward Repurchase Contracts were excluded from the computation of adjusted diluted EPS as Coty is in the position to receive shares from the counterparties and as such their inclusion would be anti-dilutive. Accordingly, we did not reverse the impact of the fair market value (gain) for contracts with the option to settle in shares or cash of ($6.8). For the six months ended December 31, 2022, as the Convertible Series B Preferred Stock was dilutive, an adjustment to reverse the impact of the preferred stock dividends of $6.6 was required. For the six months ended December 31, 2021, the convertible Series B Preferred Stock was antidilutive. Accordingly, we excluded the convertible Series B Preferred Stock from the diluted shares and did not adjust the earnings for the related dividend.

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(b)</sup>See a description of adjustments under "Adjusted Operating Income for Continuing Operations"

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(c)</sup>For the six months ended December 31, 2021, this amount reflects certain working capital adjustments related to the sale of the Wella Business.

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(d)</sup>The amount represents the realized and unrealized (gain) loss recognized for the change in fair value of the investment in Wella.

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(e)</sup>For the six months ended December 31, 2022, this primarily represents the loss from equity investment in KKW. For the six months ended December 31, 2021, this primarily represents a net gain on the exchange of Series B Preferred Stock closed on October 20, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(f)</sup>The amounts represent the after-tax impact of the non-GAAP adjustments included in Net loss attributable to noncontrolling interests based on the relevant noncontrolling interest percentage in the Condensed Consolidated Statements of Operations.

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(g)</sup>For the six months ended December 31, 2021, this adjustment represents the deemed dividend from the Second Exchange that closed on November 30, 2021 and the deemed dividend from the First Exchange that closed on October 20, 2021 (as disclosed and defined in Note 13—Equity Investments in our Annual Report on Form 10-K for fiscal 2022).

**FINANCIAL CONDITION**

LIQUIDITY AND CAPITAL RESOURCES

**Overview** 

Our primary sources of funds include cash expected to be generated from operations, borrowings from issuance of debt and lines of credit provided by banks and lenders in the U.S. and abroad.

Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during our first fiscal quarter in anticipation of higher global sales during the second fiscal quarter and strong cash generation in the second fiscal quarter as a result of increased demand by retailers associated with the holiday season.

Our principal uses of cash are to fund planned operating expenditures, capital expenditures, business structure realignment expenditures, interest payments, acquisitions, dividends, share repurchases and any principal payments on debt. Working capital movements are influenced by the sourcing of materials related to the production of products. Cash and working capital management initiatives, including the phasing of vendor payments and factoring of trade receivables from time-to-time, may also impact the timing and amount of our operating cash flows.

We remain focused on deleveraging our balance sheet using cash flows generated from our operations. We continue to take steps to permanently reduce our debt, in order to reduce interest costs and improve our long term profitability and cash flows. In addition, our 25.9% investment in Wella gives us the opportunity for further permanent debt reductions, if and when our equity position is divested.

Variable rate debt accounts for 31% of our total debt outstanding as of December 31, 2022. We incurred higher average variable interest rates compared to the same period in the prior year, and we expect this trend to continue throughout fiscal 2023. Higher long-term interest rates are expected to increase interest expense on our variable-rate outstanding debt. We use derivative instruments, such as interest rate swap contracts to reduce cash flow fluctuations associated with changes in variable interest rates. In the near term, certain of these interest rate swap contracts will expire and, if not replaced, this may have a negative impact on our cash flows in an economic environment with increasing variable interest rates. Currently, 63% of our variable rate debt is hedged using interest rate swap contracts.

We continue to wind down the operations of our Russian subsidiary. We anticipate incurring up to $8.0 of additional costs through completion of the wind down, and future net cash costs of $30.0 to $35.0, which will be funded by our Russian subsidiary. The amount of future costs, including cash costs, will be subject to various factors, such as additional government regulation and the resolution of legal contingencies. We have substantially completed our commercial activities in Russia. However, we anticipate that the process related to the liquidation of the Russian legal entity will take an extended period of time.

We continue to experience inflationary pressures in most markets resulting in higher commodity and supply chain costs, including material, freight, and energy costs. Further, inflationary trends in certain markets and global supply chain challenges, including component shortage, may negatively affect our future sales and operating performance. Supply chain constraints may impact the availability of raw materials used to manufacture our products which may negatively impact our ability to meet customer demands, thereby impacting our cash flows and profitability.

**Debt**

During the second quarter, we completed cash tender offers and redeemed $77.0 of our 2026 Dollar Notes and €69.7 million (approximately $72.2) of our 2026 Euro Notes. In addition, we early terminated a fragrance license and a portion of the termination payment totaling €52.5 million (approximately $55.6) was advanced to us. In accordance with the requirements of our debt agreements, we used a portion of the advance proceeds, totaling $35.8, to pay down outstanding

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

principal balances under the 2018 Coty Term B Facility. See Note 11—Debt in the notes to our Condensed Consolidated Financial Statements for additional information on our debt arrangements and prior period credit agreements, as well as definitions of capitalized terms.

**Factoring of Receivables**

From time to time, we supplement the timing of our cash flows through the factoring of trade receivables. In this regard, we have entered into factoring arrangements with financial institutions.

The net amount utilized under the factoring facilities was $199.9 and $179.3 as of December 31, 2022 and June 30, 2022, respectively. The aggregate amount of trade receivable invoices factored on a worldwide basis amounted to $795.8 and $597.9 during the six months ended December 31, 2022 and 2021, respectively.

**Cash Flows**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>December 31,** | **Six Months Ended<br>December 31,** |
| | **2022** | **2021** |
| **Condensed Consolidated Statements of Cash Flows Data:<br>(in millions)** |  |  |
| Net cash provided by operating activities | $645.4 | $734.7 |
| Net cash (used in) provided by investing activities | (45.2) | 74.5 |
| Net cash used in financing activities | (536.6) | (547.5) |

---

*Net cash provided by operating activities*

Net cash provided by operating activities was $645.4 and $734.7 for the six months ended December 31, 2022 and 2021, respectively. The decrease in cash provided by operating activities of $89.3 was primarily driven by higher net cash outflows from changes in working capital accounts despite an increase in cash related net income. The higher cash outflows from working capital accounts was driven by changes in Accrued expenses and other current liabilities, which reflects a decrease in level of accrual activity in the current year due to the sale of Wella and the timing of payments during both periods. The increase in cash related net income reflects the impact of lower costs as a percentage of net revenue during the current period compared to prior period.

*Net cash (used in) provided by investing activities*

Net cash (used in) provided by investing activities was $(45.2) and $74.5 for the six months ended December 31, 2022 and 2021, respectively. The increase in cash used in investing activities of $119.7 was mainly attributable to higher inflows in the prior year from sales of long term assets and higher outflows related to timing of capital expenditure projects in the current year. Proceeds from fees for the termination of a license agreement in the current year were greater than the prior period collection of contingent consideration from discontinued operations and partially offset the overall higher cash outflows from investing activities year over year.

*Net cash used in financing activities*

Net cash used in financing activities during the six months ended December 31, 2022 and 2021 was $536.6 and $547.5, respectively. The decrease in cash used in financing activities of $10.9 was driven mainly by higher cash outflows during the six months ended December 31, 2021 for dividend payments on Series B Preferred Stock and deferred financing fees largely offset by higher cash payments in the current year for realized losses on the settlement of foreign currency contracts. Debt related activities in both the six months ended December 31, 2022 and 2021 included net paydowns of debt which were flat year over year.

**Dividends**

On April 29, 2020, our Board of Directors suspended the payment of dividends, in keeping with our 2018 Coty Credit Agreement, as amended. As we focus on preserving cash, we expect to suspend the payment of dividends until we reach a Net debt to Adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") of 2x. Any determination to pay dividends in the future will be at the discretion of our Board of Directors.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

Dividends on the Convertible Series B Preferred Stock are payable in cash, or by increasing the amount of accrued dividends on Convertible Series B Preferred Stock, or any combination thereof, at the sole discretion of the Company. We started paying dividends on the Convertible Series B Preferred Stock in cash for the period ended June 30, 2021, and we expect to continue to pay such dividends in cash on a quarterly basis, subject to the declaration thereof by our Board of Directors. The terms of the Convertible Series B Preferred Stock restrict our ability to declare cash dividends on our common stock until all accrued dividends on the Convertible Series B Preferred Stock have been declared and paid in cash.

For additional information on our dividends, see Note 15—Equity and Convertible Preferred Stock in the notes to our Condensed Consolidated Financial Statements.

**Treasury Stock - Share Repurchase Program**

For information on our Share Repurchase Program, see Note 15—Equity and Convertible Preferred Stock in the notes to our Condensed Consolidated Financial Statements.

**Commitments and Contingencies**

See Note 18—Mandatorily Redeemable Financial Interests and Redeemable Noncontrolling Interests in the notes to our Condensed Consolidated Financial Statements for information on our United Arab Emirates subsidiary and subsidiary in the Middle East.

***Legal Contingencies***

For information on our litigation matters and Brazilian tax assessments, see Note 19—Commitments and Contingencies in the notes to our Condensed Consolidated Financial Statements. In relation to the appeal of our Brazilian tax assessments, we have entered into surety bonds of R$423.8 million (approximately $80.2) as of December 31, 2022.

**Off-Balance Sheet Arrangements**

We had undrawn letters of credit of $13.6 and $14.3 and bank guarantees of $17.8 and $17.2 as of December 31, 2022 and June 30, 2022, respectively.

**Contractual Obligations** 

Our principal contractual obligations and commitments as of June 30, 2022 are summarized in Item 7 - "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Contractual Obligations and Commitments," of our Fiscal 2022 Form 10-K. For the six months ended December 31, 2022, there have been no material changes in our contractual obligations outside the ordinary course of business.

**Critical Accounting Policies**

We believe that the critical accounting policies listed below involve our more significant judgments, assumptions and estimates and, therefore, could have the greatest potential impact on our Condensed Consolidated Financial Statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue Recognition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Equity Investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Goodwill, Other Intangible Assets and Long-Lived Assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Business Combinations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inventory; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Income Taxes.

As of December 31, 2022, there have been no material changes to the items disclosed as critical accounting policies and estimates in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II—Item 7 of our Fiscal 2022 Form 10-K.

**Item 3. *Quantitative and Qualitative Disclosures About Market Risk***

See Note 14—Derivative Instruments for updates to our foreign currency risk management and interest rate risk management. There have been no material changes in market risk from the information provided in Item 7A. Quantitative and Qualitative Disclosures About Market Risk of our Fiscal 2022 Form 10-K.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**Item 4. *Controls and Procedures.***

**Evaluation of Disclosure Controls and Procedures**

We maintain "disclosure controls and procedures," as defined in Rules 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Our management, with the participation of our Chief Executive Officer (the "CEO") and our Chief Financial Officer ("CFO"), evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2022. Based on the evaluation of our disclosure controls and procedures as of December 31, 2022, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

**Changes in Internal Control over Financial Reporting**

There were no changes in our internal control over financial reporting identified in management's evaluation pursuant to Rules 13a-15(f) of the Exchange Act during the second fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Inherent Limitations on Effectiveness of Controls**

Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

**Part II. OTHER INFORMATION**

**Item 1. *Legal Proceedings*.** 

For information on our legal matters, see Note 19—Commitments and Contingencies in the notes to our Condensed Consolidated Financial Statements.

**Item 1A. *Risk Factors.***

We have disclosed information about the risk factors that could adversely affect our business in Part I, Item 1A under the heading "Risk Factors" in our Annual Report on Form 10-K for fiscal 2022.

**Item 2. *Unregistered Sales of Equity Securities and Use of Proceeds.***

No shares of our Class A Common Stock were repurchased during the fiscal quarter ended December 31, 2022.

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**Item 6. *Exhibits, Financial Statement Schedules.***

The exhibits listed below are filed as part of this Quarterly Report on Form 10-Q:

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| <u>[31.1](exhibit311-certificationof.htm)</u> | <u>[Certification of Chief Executive Officer, pursuant to Rule 13a-14(a)](exhibit311-certificationof.htm)</u>. |
| <u>[31.2](exhibit312-certificationof.htm)</u> | <u>[Certification of Chief Financial Officer, pursuant to Rule 13a-14(a).](exhibit312-certificationof.htm)</u> |
| <u>[32.1](exhibit321-certificationof.htm)</u> | <u>[Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350.](exhibit321-certificationof.htm)</u> |
| <u>[32.2](exhibit322-certificationof.htm)</u> | <u>[Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350.](exhibit322-certificationof.htm)</u> |
| 101.INS | Inline XBRL Instance Document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). |

---

------

<u>[**Table of Contents**](#i6b5bcc02c0914a879b0955841c7adee6_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | COTY INC. | COTY INC. |
| Date: February 8, 2023 | By: | /s/Sue Nabi |
|  |  | Name: Sue Nabi |
|  |  | Title: Chief Executive Officer |
|  |  | (Principal Executive Officer) |
|  |  | /s/Laurent Mercier |
|  |  | Name: Laurent Mercier |
|  |  | Title: Chief Financial Officer |
|  |  | (Principal Financial Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification**

I, Sue Nabi, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this quarterly report on Form 10-Q of Coty Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 8, 2023&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| /s/Sue Nabi |
| Sue Nabi |
| Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**Certification**

I, Laurent Mercier, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this quarterly report on Form 10-Q of Coty Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 8, 2023

---

| |
|:---|
| /s/Laurent Mercier |
| Laurent Mercier |
| Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**Certification**

**Pursuant to Rule 13a-14(b) or**

**Rule 15d-14(b) and 18 U.S.C. Section 1350**

**(as adopted pursuant to Section 906 of the**

**Sarbanes-Oxley Act of 2002)**

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:

The quarterly report on Form 10-Q for the quarter ended December 31, 2022 (the "Report") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: February 8, 2023 | /s/ Sue Nabi |
| | Sue Nabi |
| | Chief Executive Officer |

---

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.

## Exhibit 32.2

**Exhibit 32.2**

**Certification**

**Pursuant to Rule 13a-14(b) or**

**Rule 15d-14(b) and 18 U.S.C. Section 1350**

**(as adopted pursuant to Section 906 of the**

**Sarbanes-Oxley Act of 2002)**

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:

The quarterly report on Form 10-Q for the quarter ended December 31, 2022 (the "Report") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: February 8, 2023 | /s/Laurent Mercier |
| | Laurent Mercier |
| | Chief Financial Officer |

---

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.

<br>